Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species
Abstract
1. Introduction
1.1. Development of Herbal Medicine
1.2. Application of Salvia officinalis, S. officinalis subsp. lavandulifolia, and Salvia sclarea in Phytotherapy
1.2.1. Salvia officinalis L.
1.2.2. Salvia officinalis subsp. lavandulifolia (Vahl) Gams
1.2.3. Salvia sclarea L.
2. Results
2.1. Protein, Fat, Ash Content, and Moisture in Salviae Herba Samples
2.2. Protein Amino Acids
2.2.1. Exogenous Amino Acids
2.2.2. Endogenous Protein Amino Acids
2.3. Fatty Acid Profile
2.3.1. Saturated Fatty Acids (SFAs), Monounsaturated Fatty Acids (MUFAs), and Polyunsaturated Fatty Acids (PUFAs)
2.3.2. Omega Fatty Acid Family
Omega-3 Fatty Acids
Omega-6 Fatty Acids
Omega-9 Fatty Acids
Omega-5 Fatty Acids
Omega-7 Fatty Acids
2.3.3. Qualitative and Quantitative Composition of Fatty Acids
Saturated Fatty Acid (SFAs)
Mono-Unsaturated (Monoenoic) Fatty Acids
Two-Unsaturated (Dienoic) Fatty Acids
Tri-Unsaturated (Trienoic) Fatty Acids
Four- Five and Six-Unsaturated (Tetra-, Penta-, and Hexanoic) Acids
2.4. Vitamin C
2.5. Polyphenolic Compounds
2.5.1. Cinnamic Acid Derivates
2.5.2. Benzoic Acid Derivatives
2.6. Coumarins and Phenol Aldehyde
2.7. Non-Phenolic Organic Acids
2.8. Ortho-Dihydroxyphenols
2.9. Flavonoids
2.9.1. Flavones
2.9.2. Flavanones
2.9.3. Flavonols
3. Discussion
3.1. Ash
3.2. Protein
3.3. Amino Acids
3.3.1. Exogenous Amino Acids
3.3.2. Endogenous Amino Acids
3.4. Lipids
3.5. Fatty Acids
3.5.1. Saturated Fatty Acids
3.5.2. Unsaturated Fatty Acids
3.6. Ascorbic Acid
3.7. O-Dihydroxyphenols
3.8. Phenolic Acids
3.9. Flavonoids
3.10. Quinic Acid
4. Future Research
5. Material and Methods
5.1. Plant Material
5.2. Moisture
5.3. Determination of Ash Content
5.4. Determination of Total Nitrogen and Protein Content
5.5. Qualitative and Quantitative Analysis of Amino Acids
5.6. Determination of Fat Content
5.7. Qualitative and Quantitative Analysis of Fatty Acids
5.8. Determination of Ascorbic Acid Content
5.9. Polyphenolic Compounds
5.9.1. Content of Total Ortho-Dihydroxyphenols
5.9.2. Total Flavonoid Content
5.10. Qualitative and Quantitative Analysis of Phenolic Acids and Flavonoids
5.10.1. Sample Preparation Procedure
5.10.2. HPLC Measurements
5.11. Statistical Analysis
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Laird, S.A.; Laird, S.; Burningham, M. The botanical medicine industry. In The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit-Sharing, 2nd ed.; Tenkate, K., Larid, S.A., Eds.; Chapter 4; Routledge: Abingdon, UK, 2019; pp. 78–116. [Google Scholar] [CrossRef]
- Ravi, S.; Bharadvaja, N. Market analysis of medicinal plants in India. Curr. Pharm. Biotechnol. 2019, 20, 1172–1180. [Google Scholar] [CrossRef] [PubMed]
- Banwo, K.; Olojede, A.O.; Adesulu-Dahunsi, A.T.; Verma, D.K.; Thakur, M.; Tripathy, S.; Singh, S.; Patel, A.R.; Gupta, A.K.; Aguilar, C.N.; et al. Functional importance of bioactive compounds of foods with potential health benefits: A review on recent trends. Food Biosci. 2021, 43, 101320. [Google Scholar] [CrossRef]
- Barkat, M.A.; Goyal, A.; Barkat, H.A.; Salauddin, M.; Pottoo, F.H.; Anwer, E.T. Herbal medicine: Clinical perspective and regulatory status. Comb. Chem. High Throughput Screen 2021, 24, 1573–1582. [Google Scholar] [CrossRef]
- Varshney, N.; Jain, D.; Janmeda, P.; Mitra, D. Role of medicinal plants in pharmaceutical sector: An overview. Glob. J. Biosci. Biotechnol. 2021, 10, 18–24. [Google Scholar]
- Al Harbi, A.; Haseeb, A.; Elrggal, M.E.; Bahabri, S.T.; Alzahrani, T.S.; Alotaibi, M.M.; Elnaem, M.H.; Ahmed, N.J.; Nasrullah, M.Z.; Bannan, D.F.; et al. The public knowledge, attitude, and practice of using herbal medicines in Makkah province. Arch. Pharm. Pract. 2022, 13, 35–39. [Google Scholar] [CrossRef]
- Hossain, C.M.; Gera, M.; Ali, K.A. Current status and challenges of herbal drug development and regulatory aspect: A global perspective. Asian J. Pharm. Clin. Res. 2022, 15, 31–41. [Google Scholar] [CrossRef]
- Bhattacharjee, B.; Sandhanam, K.; Ghose, S.; Barman, D.; Sahu, R.K. Market overview of herbal medicines for lifestyle diseases. In Role of Herbal Medicines: Management of Lifestyle Diseases, 1st ed.; Dhara, A.K., Mandal, S.C., Eds.; Springer Nature: Singapore, 2024; pp. 597–614. [Google Scholar] [CrossRef]
- Bosak, M.; Słowik, A. Use of complementary and alternative medicine among adults with epilepsy in a University Epilepsy Clinic in Poland. Epilepsy Behav. 2019, 98, 40–44. [Google Scholar] [CrossRef]
- Kasprzycka, K.; Kurzawa, M.; Kucharz, M.; Godawska, M.; Oleksa, M.; Stawowy, M.; Słupinska-Borowka, K.; Sznek, W.; Gisterek, I.; Boratyn-Nowicka, A.; et al. Complementary and alternative medicine use in hospitalized cancer patients—Study from Silesia, Poland. Int. J. Environ. Res. Public Health 2022, 19, 1600. [Google Scholar] [CrossRef]
- Melnyk, N.; Vlasova, I.; Skowrońska, W.; Bazylko, A.; Piwowarski, J.P.; Granica, S. Current knowledge on interactions of plant materials traditionally used in skin diseases in Poland and Ukraine with human skin microbiota. Int. J. Mol. Sci. 2022, 23, 9644. [Google Scholar] [CrossRef] [PubMed]
- Rybicka, M.; Zhao, J.; Piotrowicz, K.; Ptasnik, S.; Mitka, K.; Kocot-Kępska, M.; Hui, K.K. Promoting whole person health: Exploring the role of traditional Chinese medicine in Polish healthcare. J. Integr. Med. 2023, 21, 509–517. [Google Scholar] [CrossRef] [PubMed]
- Mattalia, G.; Stryamets, N.; Balázsi, Á.; Molnár, G.; Gliga, A.; Pieroni, A.; Sõukand, R.; Reyes-García, V. Hutsuls’ perceptions of forests and uses of forest resource in Ukrainian and Romanian Bukovina. Int. For. Rev. 2022, 24, 393–410. [Google Scholar] [CrossRef]
- Lazarou, R.; Heinrich, M. Herbal medicine: Who cares? The changing views on medicinal plants and their roles in British lifestyle. Phytother. Res. 2019, 33, 2409–2420. [Google Scholar] [CrossRef]
- Zahn, R.; Perry, N.; Perry, E.; Mukaetova-Ladinska, E.B. Use of herbal medicines: Pilot survey of UK users’ views. Complement. Ther. Med. 2019, 44, 83–90. [Google Scholar] [CrossRef] [PubMed]
- Prakofjewa, J.; Sartori, M.; Šarka, P.; Kalle, R.; Pieroni, A.; Sõukand, R. Knowledge in motion: Temporal dynamics of wild food plant use in the Polish-Lithuanian-Belarusian border region. J. Ethnobiol. Ethnomed. 2024, 20, 65. [Google Scholar] [CrossRef]
- Trumbeckaite, S.; Dauksiene, J.; Bernatoniene, J.; Janulis, V. Knowledge, attitudes, and usage of apitherapy for disease prevention and treatment among undergraduate pharmacy students in Lithuania. Evid. Based Complement. Alternat. Med. 2015, 2015, 172502. [Google Scholar] [CrossRef]
- Pranskuniene, Z.; Ratkeviciute, K.; Simaitiene, Z.; Pranskunas, A.; Bernatoniene, J. Ethnobotanical study of cultivated plants in Kaišiadorys district, Lithuania: Possible trends for new herbal based medicines. Evid. Based Complement. Alternat. Med. 2019, 2019, 3940397. [Google Scholar] [CrossRef]
- Pranskuniene, Z.; Bajoraite, R.; Simaitiene, Z.; Bernatoniene, J. Home gardens as a source of medicinal, herbal and food preparations: Modern and historical approaches in Lithuania. App. Sci. 2021, 11, 9988. [Google Scholar] [CrossRef]
- Pranskuniene, Z.; Balciunaite, R.; Simaitiene, Z.; Bernatoniene, J. Herbal medicine uses for respiratory system disorders and possible trends in new herbal medicinal recipes during COVID-19 in pasvalys district, Lithuania. Int. J. Environ. Res. Public Health 2022, 19, 8905. [Google Scholar] [CrossRef] [PubMed]
- Ünlüyol, D.; Gökçekuş, H.; Kassem, Y.; Tezer, M.; Meriçli, F.; Yavuz, D.Ö. Complementary and alternative medicines in Northern Cyprus: Public awareness, patterns of use, and attitudes. Healthcare 2023, 11, 977. [Google Scholar] [CrossRef]
- Sen, S.; Chakraborty, R. Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future. J. Tradit. Complement. Med. 2017, 7, 234–244. [Google Scholar] [CrossRef]
- Niveditha, A.S.; Geetha, R.V. Knowledge and awareness of natural anticarcinogenic herbs among the general population. Drug Invent. Today 2020, 14, 1245–1248. [Google Scholar]
- Singh, G.; Sahu, P.; Sharma, A.; Butool, B.; Sarkar, R.; Mishra, R.; Soni, R. Public awareness about the usage of medicinal herbs found in the kitchen and their potential against COVID-19 disease. Plant Arch. 2022, 22, 288–296. [Google Scholar] [CrossRef]
- Hussain, T.; Ishtiaq, M. Public awareness and bio-management of COVID-19 by four medicinal herbs in district Bhimber, Azad Kashmir, Pakistan: Public awareness and bio-management of COVID-19 by four medicinal herbs. Proc. Pak. Acad. Sci. B. Life Environ. Sci. 2021, 58, 69–76. [Google Scholar]
- Zaidi, S.F.; Saeed, S.A.; Khan, M.A.; Khan, A.; Hazazi, Y.; Otayn, M.; Rabah, M.; Daniyal, M. Public knowledge, attitudes, and practices towards herbal medicines; a cross-sectional study in Western Saudi Arabia. BMC Complement. Med. Ther. 2022, 22, 326. [Google Scholar] [CrossRef]
- Alhindi, Y.Z.; Habib, A.A.; Alhusini, R.H.; Bahha, A.S.; Alqurashi, A.E.; Almatani, R.S.; Alharbi, B.; Alharthy, M.H.; Alharbi, F.R.; Sendi, O.; et al. Beliefs about the use of herbs before and after COVID-19: A cross-sectional study in Saudi Arabia. Cureus 2023, 15, 49624. [Google Scholar] [CrossRef] [PubMed]
- İduğ, T. Herbal food supplements usage awareness of university students: Example of Echinacea and St. John’s Wort. Int. J. Agric. Environ. Food Sci. 2023, 7, 792–797. [Google Scholar] [CrossRef]
- Chidimma, E.A.D.; Tom, C.I. Public awareness and attitude towards herbal medicine campaigns for the prevention and treatment of sexually transmitted diseases in South-East Nigeria. Int. J. Sci. Res. Publ. 2018, 8, 366–373. [Google Scholar] [CrossRef]
- Bhuyan, D.J.; Dissanayake, I.H.; Jaye, K.; Chang, D. Traditional and complementary medicine in Australia: Clinical practice, research, education, and regulation. Int. J. Ayurveda Res. 2022, 3, 16–29. [Google Scholar] [CrossRef]
- Job, K.M.; Kiang, T.K.; Constance, J.E.; Sherwin, C.M.; Enioutina, E.Y. Herbal medicines: Challenges in the modern world. Part 4. Canada and United States. Expert Rev. Clin. Pharmacol. 2016, 9, 1597–1609. [Google Scholar] [CrossRef]
- Rashrash, M.; Schommer, J.C.; Brown, L.M. Prevalence and predictors of herbal mdicine use among adults in the United States. J. Patient Exp. 2017, 4, 108–113. [Google Scholar] [CrossRef]
- Ghorbani, A.; Esmaeilizadeh, M. Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med. 2017, 7, 433–440. [Google Scholar] [CrossRef]
- Oresanya, I.O.; Orhan, I.E. Deciphering neuroprotective effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through preclinical and clinical studies. Curr. Drug Targets 2024, 25, 330–352. [Google Scholar] [CrossRef]
- Jiang, Y.; Zhang, L.; Rupasinghe, H.V. Antiproliferative effects of extracts from Salvia officinalis L. and Saliva miltiorrhiza Bunge on hepatocellular carcinoma cells. Biomed. Pharmacother. 2017, 85, 57–67. [Google Scholar] [CrossRef]
- Grzegorczyk, I.; Królicka, A.; Wysokińska, H. Establishment of Salvia officinalis L. hairy root cultures for the production of rosmarinic acid. Z. Naturforsch C. J. Biosci. 2006, 61, 351–356. [Google Scholar] [CrossRef]
- Kianbakht, S.; Abasi, B.; Perham, M.; Hashem Dabaghian, F. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: A randomized double-blind placebo-controlled clinical trial. Phytother. Res. 2011, 25, 1849–1853. [Google Scholar] [CrossRef] [PubMed]
- Garcia, C.S.C.; Ely, M.R.; Wasum, R.A.; Zoppa, B.C.A.; Wollheim, C.; Neves, G.Â.; Angeli, V.W.; de Souza, K.C.B. Assessment of Salvia officinalis (L.) hydroalcoholic extract for possible use in cosmetic formulation as inhibitor of pathogens in the skin. Rev. Ciênc. Farm. Básica Apl. 2012, 33, 509–514. [Google Scholar]
- Jurca, T.; Baldea, I.; Filip, G.A.; Olteanu, D.; Clichici, S.; Pallag, A.; Vicaş, L.; Marian, E.; Micle, O.; Crivii, C.B.; et al. Phytocomplex consisting of Tropaeolum majus L. and Salvia officinalis L. extracts alleviates the inflammatory response of dermal fibroblasts to bacterial lipopolysaccharides. Oxid. Med. Cell Longev. 2020, 2020, 8516153. [Google Scholar] [CrossRef] [PubMed]
- Monsen, R.E.; Herlofson, B.B.; Gay, C.; Fjeld, K.G.; Hove, L.H.; Malterud, K.E.; Saghaug, E.; Slaaen, J.; Sundal, T.; Tollisen, A.; et al. Mouth rinse based on a tea solution of Salvia officinalis for oral discomfort in palliative cancer care: A randomized controlled trial. Support. Care Cancer 2021, 29, 4997–5007. [Google Scholar] [CrossRef]
- Mot, M.D.; Gavrilaș, S.; Lupitu, A.I.; Moisa, C.; Chambre, D.; Tit, D.M.; Bogdan, M.A.; Bodescu, A.M.; Copolovici, L.; Copolovici, D.M.; et al. Salvia officinalis L. essential oil: Characterization, antioxidant properties, and the effects of aromatherapy in adult patients. Antioxidants 2022, 11, 808. [Google Scholar] [CrossRef]
- Alomar, H.A.; Elkady, W.M.; Abdel-Aziz, M.M.; Ibrahim, T.A.; Fathallah, N. Anti-Heliobacter pylori and anti-inflammatory potential of Salvia officinalis metabolites: In vitro and in silico studies. Metabolites 2023, 13, 136. [Google Scholar] [CrossRef]
- Öztürk, G.; Demirci, B.; Demirci, F. Evaluation of the chemical composition and biological activities of Salvia officinalis subsp. lavandulifolia (Vahl) Gams essential oil. Nat. Volatiles Essent. Oils 2018, 5, 1–6. [Google Scholar]
- Rabilu, S.A.; Agyemang, E.D.; Farkas, B. Antifungal activity of Salvia officinalis subsp. lavandulifolia and Salvia officinalis subsp. major aqueous extracts against Botrytis cinerea. J. Cent. Eur. Agric. 2021, 22, 420–428. [Google Scholar] [CrossRef]
- Dosoky, N.S.; Poudel, A.; Satyal, P.; Setzer, W.N. Volatile composition and enantiomeric distribution of spanish sage (Salvia officinalis subsp. lavandulifolia [Vahl] Gams) from Spain. Nat. Prod. Commun. 2022, 17, 1934578X221139402. [Google Scholar] [CrossRef]
- Fiore, G.; Nencini, C.; Cavallo, F.; Capasso, A.; Bader, A.; Giorgi, G.; Micheli, L. In vitro antiproliferative effect of six Salvia species on human tumor cell lines. Phytother. Res. 2006, 20, 701–703. [Google Scholar] [CrossRef]
- Różalski, M.; Kuźma, Ł.; Wysokińska, H.; Krajewska, U. Cytotoxic and proapoptotic activity of diterpenoids from in vitro cultivated Salvia sclarea roots. Studies on the leukemia cell lines. Z. Naturforsch. C. J. Biosci. 2006, 61, 483–488. [Google Scholar] [CrossRef] [PubMed]
- Kuźma, Ł.; Różalski, M.; Walencka, E.; Różalska, B.; Wysokińska, H. Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: Salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine 2007, 14, 31–35. [Google Scholar] [CrossRef] [PubMed]
- Kuźma, L.; Bruchajzer, E.; Wysokińska, H. Diterpenoid production in hairy root culture of Salvia sclarea L. Z. Naturforsch. C J. Biosci. 2008, 63, 621–624. [Google Scholar] [CrossRef]
- Cui, H.; Zhang, X.; Zhou, H.; Zhao, C.; Lin, L. Antimicrobial activity and mechanisms of Salvia sclarea essential oil. Bot. Stud. 2015, 56, 16. [Google Scholar] [CrossRef] [PubMed]
- Aćimović, M.; Kiprovski, B.; Rat, M.; Sikora, V.; Popović, V.; Koren, A.; Brdar-Jokanović, M. Salvia sclarea: Chemical composition and biological activity. J. Agron. Technol. Eng. Manag. 2018, 1, 18–28. [Google Scholar]
- Raafat, K.; Habib, J. Phytochemical compositions and antidiabetic potentials of Salvia sclarea L. Essential Oils. J. Oleo Sci. 2018, 67, 1015–1025. [Google Scholar] [CrossRef]
- Wong, J.; Chiang, Y.F.; Shih, Y.H.; Chiu, C.H.; Chen, H.Y.; Shieh, T.M.; Wang, K.L.; Huang, T.C.; Hong, Y.H.; Hsia, S.M. Salvia sclarea L. essential oil extract and its antioxidative phytochemical sclareol inhibit oxytocin-induced uterine hypercontraction dysmenorrhea model by inhibiting the Ca2+-MLCK-MLC20 signaling cascade: An ex vivo and in vivo study. Antioxidants 2020, 9, 991. [Google Scholar] [CrossRef]
- Zhussupova, A.; Zhumaliyeva, G.; Ogay, V.; Issabekova, A.; Ross, S.A.; Zhusupova, G.E. Immunomodulatory effects of plant extracts from Salvia deserta Schang. and Salvia sclarea L. Plants 2022, 11, 2690. [Google Scholar] [CrossRef]
- Kačániová, M.; Vukovic, N.L.; Čmiková, N.; Galovičová, L.; Schwarzová, M.; Šimora, V.; Kowalczewski, P.Ł.; Kluz, M.I.; Puchalski, C.; Bakay, L.; et al. Salvia sclarea essential oil chemical composition and biological activities. Int. J. Mol. Sci. 2023, 24, 5179. [Google Scholar] [CrossRef] [PubMed]
- Zdrojewicz, Z.; Pypno, D.; Bugaj, B.; Cabała, K.; Waracki, M. Applications of Salvia in treating cognitive disorders and Alzheimer’s disease. Post. Fitot. 2015, 4, 263–267. [Google Scholar]
- Fawzi, M.; Kamel, Z.; Farhan, S. Anti-inflammatory effect of sage (Salvia officinalis) extracts on oral health. Iraqi Dent. J. 2017, 39, 1–6. [Google Scholar] [CrossRef]
- Weishaupt, R.; Buchkov, A.; Kolev, E.; Klein, P.; Schoop, R. Reduction of viral load in patients with acute sore throats: Results from an observational clinical trial with Echinacea/Salvia Lozenges. Complement. Med. Res. 2023, 30, 299–306. [Google Scholar] [CrossRef]
- Nicolella, H.D.; Fernandes, G.; Ozelin, S.D.; Rinaldi-Neto, F.; Ribeiro, A.B.; Furtado, R.A.; Senedese, J.M.; Esperandim, T.R.; Veneziani, R.C.S.; Tavares, D.C. Manool, a diterpene from Salvia officinalis, exerts preventive effects on chromosomal damage and preneoplastic lesions. Mutagenesis 2021, 36, 177–185. [Google Scholar] [CrossRef]
- Amini, L.; Mojab, F.; Jahanfar, S.; Sepidarkish, M.; Raoofi, Z.; Maleki-Hajiagha, A. Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial. Complement. Ther. Med. 2020, 48, 102245. [Google Scholar] [CrossRef] [PubMed]
- Ahmad, S.; Ahmed, S.B.; Khan, A.; Wasim, M.; Tabassum, S.; Haider, S.; Ahmed, F.; Batool, Z.; Khaliq, S.; Rafiq, H.; et al. Natural remedies for Alzheimer’s disease: A systematic review of randomized controlled trials. Metab. Brain Dis. 2023, 38, 17–44. [Google Scholar] [CrossRef]
- Ertas, A.; Yigitkan, S.; Orhan, I.E. A focused review on cognitive improvement by the genus Salvia L. (Sage)-from ethnopharmacology to clinical evidence. Pharmaceuticals 2023, 16, 171. [Google Scholar] [CrossRef]
- Martínez-Francés, V.; Hahn, E.; Ríos, S.; Rivera, D.; Reich, E.; Vila, R.; Cañigueral, S. Ethnopharmacological and chemical characterization of Salvia species used in valencian traditional herbal preparations. Front. Pharmacol. 2017, 8, 467. [Google Scholar] [CrossRef] [PubMed]
- Kostić, M.; Kitić, D.; Petrović, M.B.; Jevtović-Stoimenov, T.; Jović, M.; Petrović, A.; Živanović, S. Anti-inflammatory effect of the Salvia sclarea L. ethanolic extract on lipopolysaccharide-induced periodontitis in rats. J. Ethnopharmacol. 2017, 199, 52–59. [Google Scholar] [CrossRef] [PubMed]
- Shanaida, M.; Hudz, N.; Białoń, M.; Kryvtsowa, M.; Svydenko, L.; Filipska, A.; Wieczorek, P.P. Chromatographic profiles and antimicrobial activity of the essential oils obtained from some species and cultivars of the mentheae tribe (Lamiaceae). Saudi J. Biol. Sci. 2021, 28, 6145–6152. [Google Scholar] [CrossRef]
- Khalil, E.; Esoh, R.; Rababah, T.; Almajwal, A.; Alu‘datt, M.H. Minerals, proximate composition and their correlations of medicinal plants from Jordan. J. Med. Plant Res. 2012, 6, 5757–5762. [Google Scholar]
- Dziadek, K.; Kopeć, A.; Dziadek, M.; Sadowska, U.; Cholewa-Kowalska, K. The changes in bioactive compounds and antioxidant activity of chia (Salvia hispanica L.) herb under storage and different drying conditions: A comparison with other species of sage. Molecules 2022, 27, 1569. [Google Scholar] [CrossRef]
- Darwish, A.; Hamad, G.; Sohaimy, S. Nutrients and constituents relevant to antioxidant, antimicrobial and anti-breast cancer properties of Salvia officinalis L. Int. J. Biochem. Res. Rev. 2018, 23, 1–13. [Google Scholar] [CrossRef]
- Todorova, M.; Grigorova, S.; Gjorgovska, N. Effects of sage (Salvia officinalis L.) supplementation in hen diets on laying productivity, egg quality, and biochemical parameters. Acta Fytotech. Zootech. 2024, 27, 143–150. [Google Scholar] [CrossRef]
- Draz, S.N.; Ali, A.M.F.; Hussein, K.E.; Afifi, A.K.S. A comparative study between green tea (Camellia sinensis) and common sage (Salvia officinalis) (chemical composition and active compounds). Menoufia J. Agric. Biotech. 2021, 6, 11–21. [Google Scholar] [CrossRef]
- Peiretti, P.G.; Gai, F. Fatty acid and nutritive quality of chia (Salvia hispanica L.) seeds and plant during growth. Anim. Feed Sci. Technol. 2009, 148, 267–275. [Google Scholar] [CrossRef]
- Laftouhi, A.; Eloutassi, N.; Ech-Chihbi, E.; Kara, M.; Assouguem, A.; Ali, E.A.; Fidan, H.; Rais, Z.; Taleb, A.; Beniken, M.; et al. Impact of climatic disturbances on the chemical compositions and metabolites of Salvia officinalis. Open Chem. 2023, 21, 20230115. [Google Scholar] [CrossRef]
- Grancieri, M.; Martino, H.S.D.; de Mejia, E.G. Chia (Salvia hispanica L.) seed total protein and protein fractions digests reduce biomarkers of inflammation and atherosclerosis in macrophages in vitro. Mol. Nutr. Food Res. 2019, 63, e1900021. [Google Scholar] [CrossRef]
- Orona-Tamayo, D.; Valverde, M.E.; Nieto-Rendón, B.; Paredes-López, O. Inhibitory activity of chia (Salvia hispanica L.) protein fractions against angiotensin I-converting enzyme and antioxidant capacity. LWT—Food Sci. Technol. 2015, 64, 236–242. [Google Scholar] [CrossRef]
- Medeiros, A.; Bianchi, S.; Calvete, J.J.; Balter, H.; Bay, S.; Robles, A.; Cantacuzène, D.; Nimtz, M.; Alzari, P.M.; Osinaga, E. Biochemical and functional characterization of the Tn-specific lectin from Salvia sclarea seeds. Eur. J. Biochem. 2000, 267, 1434–1440. [Google Scholar] [CrossRef]
- Bahadour, M.; Aboutalebi Jahromi, A.; Behroznam Jahromi, B.; Rowshan, V. Growth characteristics and changes in the active ingredients of Salvia mirzayanii essential oil under foliar application of humic acid and amino acid. J. Med. Plants By-Prod. 2023, 13, 560–569. [Google Scholar] [CrossRef]
- Farruggia, D.; Di Miceli, G.; Licata, M.; Leto, C.; Salamone, F.; Novak, J. Foliar application of various biostimulants produces contrasting response on yield, essential oil and chemical properties of organically grown sage (Salvia officinalis L.). Front. Plant Sci. 2024, 15, 1397489. [Google Scholar] [CrossRef] [PubMed]
- Khammar, A.A.; Moghaddam, M.; Asgharzade, A.; Sourestani, M.M. Nutritive composition, growth, biochemical traits, essential oil content and compositions of Salvia officinalis L. grown in different nitrogen levels in soilless culture. J. Soil. Sci. Plant Nutr. 2021, 21, 3320–3332. [Google Scholar] [CrossRef]
- Koshevoi, O.N. Amino-acid and monosaccharide compositions of Salvia officinalis leaves. Chem. Nat. Compd. 2011, 47, 492–493. [Google Scholar] [CrossRef]
- Vovk, G.V.; Koshovyi, O.M.; Komissarenko, A.M. The amino-acid and monosaccharide composition of a dry extract from Salvia officinalis leaves obtained by complex processing. News Pharm. 2016, 1, 33–35. [Google Scholar] [CrossRef]
- Oh, G.S.; Lee, J.H.; Byun, K.; Kim, D.I.; Park, K.D. Effect of intake of leucine-rich protein supplement in parallel with resistance exercise on the body composition and function of healthy adults. Nutrients 2022, 14, 4501. [Google Scholar] [CrossRef]
- Theis, N.; Brown, M.A.; Wood, P.; Waldron, M. Leucine supplementation increases muscle strength and volume, reduces inflammation, and affects wellbeing in adults and adolescents with cerebral palsy. J. Nutr. 2021, 151, 59–64. [Google Scholar] [CrossRef]
- Kang, Y.; Kim, N.; Choi, Y.J.; Lee, Y.; Yun, J.; Park, S.J.; Park, Y.K. Supplementation increases lean body mass in healthy Korean adults aged 50 years and older: A randomized, double-blind, placebo-controlled trial. Nutrients 2020, 12, 1816. [Google Scholar] [CrossRef]
- Holeček, M. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions. J. Cachexia Sarcopenia Muscle (JCSM) 2017, 8, 529–541. [Google Scholar] [CrossRef]
- Kaczka, P.; Michalczyk, M.M.; Jastrząb, R.; Gawelczyk, M.; Kubicka, K. Mechanism of action and the effect of Beta-Hydroxy-Beta-Methylbutyrate (HMB) supplementation on different types of physical performance—A systematic review. J. Hum. Kinet. 2019, 68, 211–222. [Google Scholar] [CrossRef]
- Wang, X.J.; Yang, X.; Wang, R.X.; Jiao, H.C.; Zhao, J.P.; Song, Z.G.; Lin, H. Leucine alleviates dexamethasone-induced suppression of muscle protein synthesis via synergy involvement of mTOR and AMPK pathways. Biosci. Rep. 2016, 36, 00346. [Google Scholar] [CrossRef]
- Zhang, B.; Chu, L.; Liu, H.; Xie, C.; Qiao, S.; Zeng, X. Leucine supplementation in a chronically protein-restricted diet enhances muscle weight and postprandial protein synthesis of skeletal muscle by promoting the mTOR pathway in adult rats. Engineering 2017, 3, 760–765. [Google Scholar] [CrossRef]
- Zhao, Y.; Cholewa, J.; Shang, H.; Yang, Y.; Ding, X.; Liu, S.; Xia, Z.; Zanchi, N.E.; Wang, Q. Exercise may promote skeletal muscle hypertrophy via enhancing leucine-sensing: Preliminary evidence. Front. Physiol. 2021, 12, 741038. [Google Scholar] [CrossRef] [PubMed]
- Byfield, M.P.; Murray, J.T.; Backer, J.M. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 2005, 280, 33076–33082. [Google Scholar] [CrossRef]
- Drummond, M.J.; Rasmussen, B. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 222–226. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Cholewa, J.; Shang, H.; Yang, Y.; Ding, X.; Wang, Q.; Su, Q.; Zanchi, N.E.; Xia, Z. Advances in the role of leucine-sensing in the regulation of protein synthesis in aging skeletal muscle. Front. Cell Dev. Biol. 2021, 9, 646482. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, M.L.; Signor, A.; Neu, D.H. Importance of aromatic amino acids phenylalanine and tyrosine in fish nutrition. Ciênc. Anim. 2019, 29, 71–83. [Google Scholar]
- Akram, M.; Daniyal, M.; Ali, A.; Zainab, R.; Muhammad, S.; Shah, A.; Munir, N.; Tahir, I.M. Role of phenylalanine and its metabolites in health and neurological disorders. In Synucleins—Biochemisty and Role in Diseases; Surguchov, A., Ed.; Chapter 5; IntechOpen: London, UK, 2020; pp. 1–13. [Google Scholar] [CrossRef]
- Dratman, M.B.; Martin, J.V. The many faces of thyroxine. AIMS Neurosci. 2020, 7, 17–29. [Google Scholar] [CrossRef]
- Yang, J.; Yan, B.; Zhao, B.; Fan, Y.; He, X.; Yang, L.; Ma, Q.; Zheng, J.; Wang, W.; Bai, L.; et al. Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders. Schizophr. Bull. 2020, 46, 804–813. [Google Scholar] [CrossRef]
- Luo, L.; Zeng, H.; Hu, Y.; Jiang, L.; Fu, C.; Huang, J.; Chen, J.; Zeng, Q. The amino acid transporter SLC16A10 promotes melanogenesis by facilitating the transportation of phenylalanine. Exp. Dermatol. 2024, 33, 15165. [Google Scholar] [CrossRef]
- Farishian, R.A.; Writtaker, J.H. Phenylalanine lowers melanin synthesis in mammalian melanocytes by reducing tyrosinase uptake: Implications for pigment reduction in phenylketonuria. J. Investig. Dermatol. 1980, 74, 85–89. [Google Scholar] [CrossRef]
- Hirayama, M.; Tsunoda, M.; Yamamoto, M.; Tsuda, T.; Ohno, K. Serum tyrosine-to-phenylalanine ratio is low in Parkinson’s disease. J. Park. Dis. 2016, 6, 423–443. [Google Scholar] [CrossRef]
- Teraishi, T.; Kajiwara, M.; Hori, H.; Sasayama, D.; Hidese, S.; Matsuo, J.; Ishida, I.; Kajiwara, Y.; Ozeki, Y.; Ota, M.; et al. 13C-phenylalanine breath test and serum biopterin in schizophrenia, bipolar disorder and major depressive disorder. J. Psychiatr. Res. 2018, 99, 142–150. [Google Scholar] [CrossRef]
- Moreno Adaro, O.F.; Berríos Bravo, C.; Guevara, M.A.; Mesones, G.; Sabina, L.; Mulet, D.; Okasova, A.; Andrada, R.; Gargiulo, Á.J.M.; Gargiulo, M.M.L.; et al. Comparative effect between antidepressants and D-phenylalanine, a phenethylamine precursor, in an animal model of depression. Arch. Psychiatry Res. 2023, 59, 219–224. [Google Scholar] [CrossRef]
- Li, S.; Song, H.; Yu, C. Causal association between phenylalanine and Parkinson’s disease: A two-sample bidirectional mendelian randomization study. Front. Genet. 2024, 15, 1322551. [Google Scholar] [CrossRef] [PubMed]
- Shebl, N.; El-Jaafary, S.; Saeed, A.A.; Elkafrawy, P.; El-Sayed, A.; Shamma, S.; Elnemr, R.; Mekky, J.; Mohamed, L.A.; Kittaneh, O.; et al. Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort. Front. Mol. Biosci. 2024, 11, 1341950. [Google Scholar] [CrossRef] [PubMed]
- Olianas, M.C.; Ambu, R.; Garau, L.; Onali, P. Allosteric modulation of GABA(B) receptor function in human frontal cortex. Neurochem. Int. 2005, 46, 149–158. [Google Scholar] [CrossRef]
- Jembrek, M.J.; Vlainic, J. GABA receptors: Pharmacological potential and pitfalls. Curr. Pharm. Des. 2015, 21, 4943–4959. [Google Scholar] [CrossRef]
- Maler, V.; Goetz, V.; Tardieu, M.; El Khalil, A.; Alili, J.M.; Meunier, P.; Maillot, F.; Labarthe, F. Aspartame and Phenylketonuria: An analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France. Orphanet J. Rare Dis. 2023, 18, 142. [Google Scholar] [CrossRef] [PubMed]
- Grahnemo, L.; Eriksson, A.L.; Nethander, M.; Johansson, R.; Lorentzon, M.; Mellström, D.; Pettersson-Kymmer, U.; Ohlsson, C. Low circulating valine associate with high risk of hip fractures. J. Clin. Endocrinol. Metab. 2023, 108, 1384–1393. [Google Scholar] [CrossRef] [PubMed]
- Siahbalaei, R.; Kavoosi, G. In vitro antidiabetic activity of free amino acids and protein amino acid extracts from four Iranian medicinal plants. Iran. J. Sci. Technol. Trans. Sci. 2021, 45, 443–454. [Google Scholar] [CrossRef]
- Sharma, S.; Zhang, X.; Azhar, G.; Patyal, P.; Verma, A.; Kc, G.; Wei, J.Y. Valine improves mitochondrial function and protects against oxidative stress. Biosci. Biotechnol. Biochem. 2024, 88, 168–176. [Google Scholar] [CrossRef]
- Thandapani, P.; Kloetgen, A.; Witkowski, M.T.; Glytsou, C.; Lee, A.K.; Wang, E.; Wang, J.; LeBoeuf, S.E.; Avrampou, K.; Papagiannakopoulos, T.; et al. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature 2022, 601, 428–433. [Google Scholar] [CrossRef]
- Myha, M.; Koshovyi, O.; Gamulya, O.; Ilina, T.; Borodina, N.; Vlasova, I. Phytochemical study of Salvia grandiflora and Salvia officinalis leaves for establishing prospects for use in medical and pharmaceutical practice. ScienceRise Pharm. Sci. 2020, 1, 23–28. [Google Scholar] [CrossRef]
- Piller, V.; Piller, F.; Cartron, J.P. Isolation and characterization of an N-acetylgalactosamine specific lectin from Salvia sclarea seeds. J. Biol. Chem. 1986, 261, 14069–14075. [Google Scholar] [CrossRef]
- Kara, Y.; Kocak, A.; Citil, O.B.; Tulukcu, E. A comparative study of the fatty acid composition and lipid content of Salvia sclarea. Chem. Nat. Compd. 2010, 46, 612–614. [Google Scholar] [CrossRef]
- Emre, I.; Kursat, M. Biochemical parameters and antioxidant property of three Salvia L. taxa endemic in Turkey. Braz. J. Biol. 2021, 82, 239539. [Google Scholar] [CrossRef]
- Bagci, E.; Vural, M.; Dirmenci, T.; Bruehl, L.; Aitzetmüllerd, K. Fatty acid and tocochromanol patterns of some Salvia L. species. Z. Naturforsch. C J. Biosci. C 2004, 59, 305–309. [Google Scholar] [CrossRef]
- Carta, G.; Murru, E.; Banni, S.; Manca, C. Palmitic acid: Physiological role, metabolism, and nutritional implications. Front. Physiol. 2017, 8, 902. [Google Scholar] [CrossRef]
- German, J.B. Dietary lipids from an evolutionary perspective: Sources, structures and functions. Matern. Child Nutr. 2011, 7, 2–16. [Google Scholar] [CrossRef]
- Innis, S.M. Palmitic acid in early human development. Crit. Rev. Food Sci. Nutr. 2016, 56, 1952–1959. [Google Scholar] [CrossRef]
- Korbecki, J.; Bajdak-Rusinek, K. The effect of palmitic acid on inflammatory response in macrophages: An overview of molecular mechanisms. Inflamm. Res. 2019, 68, 915–932. [Google Scholar] [CrossRef]
- Vazquez-Jimenez, J.G.; Chavez-Reyes, J.; Romero-Garcia, T.; Zarain-Herzberg, A.; Valdes-Flores, J.; Galindo-Rosales, J.M.; Rueda, A.; Guerrero-Hernandez, A.; Olivares-Reyes, J.A. Palmitic acid but not palmitoleic acid induces insulin resistance in a human endothelial cell line by decreasing SERCA pump expression. Cell. Signal. 2016, 28, 53–59. [Google Scholar] [CrossRef]
- Mu, Y.M.; Yanase, T.; Nishi, Y.; Tanaka, A.; Saito, M.; Jin, C.H.; Mukasa, C.; Okabe, T.; Nomura, M.; Goto, K.; et al. Saturated FFAs, palmitic acid and stearic acid, induce apoptosis in human granulosa cells. Endocrinology 2001, 142, 3590–3597. [Google Scholar] [CrossRef] [PubMed]
- Lu, Z.H.; Mu, Y.M.; Wang, B.A.; Li, X.L.; Lu, J.M.; Li, J.Y.; Pan, C.Y.; Yanase, T.; Nawata, H. Saturated free fatty acids, palmitic acid and stearic acid, induce apoptosis by stimulation of ceramide generation in rat testicular Leydig cell. Biochem. Biophys. Res. Commun. 2003, 303, 1002–1007. [Google Scholar] [CrossRef] [PubMed]
- Shen, X.; Miao, S.; Zhang, Y.; Guo, X.; Li, W.; Mao, X.; Zhang, Q. Stearic acid metabolism in human health and disease. Clin. Nutr. 2024, 44, 222–238. [Google Scholar] [CrossRef]
- Mukherjee, S.; Edmunds, M.; Lei, X.; Ottaviani, M.F.; Ananthapadmanabhan, K.P.; Turro, N.J. Original Contribution: Stearic acid delivery to corneum from a mild and moisturizing cleanser. J. Cosmet. Dermatol. 2010, 9, 202–210. [Google Scholar] [CrossRef] [PubMed]
- Ananthapadmanabhan, K.P.; Mukherjee, S.; Chandar, P. Stratum corneum fatty acids: Their critical role in preserving barrier integrity during cleansing. Int. J. Cosmet. Sci. 2013, 35, 337–345. [Google Scholar] [CrossRef] [PubMed]
- Pereira-Leite, C.; Bom, M.; Ribeiro, A.; Almeida, C.; Rosado, C. Exploring stearic-acid-based nanoparticles for skin applications—Focusing on stability and cosmetic benefits. Cosmetics 2023, 10, 99. [Google Scholar] [CrossRef]
- Schafer, N.; Balwierz, R.; Biernat, P.; Ochędzan-Siodłak, W.; Lipok, J. Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum. Mol. Pharm. 2023, 20, 3278–3297. [Google Scholar] [CrossRef]
- Sanders, T.A.; Oakley, F.R.; Cooper, J.A.; Miller, G.J. Influence of a stearic acid–rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects. Am. J. Clin. Nutr. 2001, 73, 715–721. [Google Scholar] [CrossRef] [PubMed]
- Sanders, T.A.; Berry, S.E. Influence of stearic acid on postprandial lipemia and hemostatic function. Lipids 2005, 40, 1221–1227. [Google Scholar] [CrossRef]
- Wang, Z.J.; Liang, C.L.; Li, G.M.; Yu, C.Y.; Yin, M. Stearic acid protects primary cultured cortical neurons against oxidative stress. Acta Pharmacol. Sin. 2007, 28, 315–326. [Google Scholar] [CrossRef]
- Mensink, R.P. Effects of stearic acid on plasma lipid and lipoproteins in humans. Lipids 2005, 40, 1201–1205. [Google Scholar] [CrossRef]
- Evans, L.M.; Cowey, S.L.; Siegal, G.P.; Hardy, R.W. Stearate preferentially induces apoptosis in human breast cancer cells. Nutr. Cancer 2009, 61, 746–753. [Google Scholar] [CrossRef]
- Alonso-Castro, A.J.; Serrano-Vega, R.; Perez Gutierrez, S.; Isiordia-Espinoza, M.A.; Solorio-Alvarado, C.R. Myristic acid reduces skin inflammation and nociception. J. Food Biochem. 2022, 46, 14013. [Google Scholar] [CrossRef]
- Tanjung, C.; Harris, C.P.; Demmelmair, H.; Dwitya, S.; Munasir, Z.; Sudoyo, H.; Standl, M.; Sjarif, D.R.; Koletzko, B. Novel interactions of myristic acid and FADS3 variants predict atopic dermatitis among Indonesian infants. Nutrients 2022, 14, 4676. [Google Scholar] [CrossRef]
- Gutiérrez-García, A.G.; Contreras, C.M.; Díaz-Marte, C. Myristic acid in amniotic fluid produces appetitive responses in human newborns. Early Hum. Dev. 2017, 115, 32–37. [Google Scholar] [CrossRef]
- Ying, M.; Wang, S.; Zhang, M.; Wang, R.; Zhu, H.; Ruan, H.; Ran, D.; Chai, Z.; Wang, X.; Lu, W. Myristic acid-modified DA7R peptide for whole-process glioma-targeted drug delivery. ACS Appl. Mater. Interfaces 2018, 10, 19473–19482. [Google Scholar] [CrossRef] [PubMed]
- Olivieri, O.; Speziali, G.; Castagna, A.; Pattini, P.; Udali, S.; Pizzolo, F.; Liesinger, L.; Gindlhuber, J.; Tomin, T.; Schittmayer, M.; et al. The positive association between plasma myristic acid and ApoCIII concentrations in cardiovascular disease patients is supported by the effects of myristic acid in HepG2 cells. J. Nutr. 2020, 150, 2707–2715. [Google Scholar] [CrossRef]
- Yuan, S.; Li, X.; Morange, P.E.; Bruzelius, M.; Larsson, S.C.; Invent Consortium. Plasma phospholipid fatty acids and risk of venous thromboembolism: Mendelian randomization investigation. Nutrients 2022, 14, 3354. [Google Scholar] [CrossRef]
- Zhu, P.; Fan, L.; Yan, X.; Li, J. Advances of α-linolenic acid: Sources, extraction, biological activity and its carrier. Trends Food Sci. Technol. 2024, 152, 104676. [Google Scholar] [CrossRef]
- Gross, M.; Nesher, E.; Tikhonov, T.; Raz, O.; Pinhasov, A. Chronic food administration of Salvia sclarea oil reduces animals’ anxious and dominant behavior. J. Med. Food. 2013, 16, 216–222. [Google Scholar] [CrossRef]
- Saini, R.K.; Prasad, P.; Sreedhar, R.V.; Naidu, K.A.; Shang, X.; Keum, Y.S. Omega-3 polyunsaturated fatty acids (PUFAs): Emerging plant and microbial sources, oxidative stability, bioavailability, and health benefits-a review. Antioxidants 2021, 10, 1627. [Google Scholar] [CrossRef]
- Zhou, W.; Zhu, B.; Kou, F.; Qi, S.; Lv, C.; Cheng, Y.; Wei, H. Targeted metabolic profiling and PRM analysis of proteins revealed impaired polyunsaturated fatty acid metabolism and GTP metabolism in the brainstem of spontaneously hypertensive rats. J. Proteome Res. 2021, 20, 3305–3314. [Google Scholar] [CrossRef]
- Iino, T.; Toh, R.; Nagao, M.; Shinohara, M.; Harada, A.; Murakami, K.; Irino, Y.; Nishimori, M.; Yoshikawa, S.; Seto, Y.; et al. Effects of elaidic acid on HDL cholesterol uptake capacity. Nutrients 2021, 13, 3112. [Google Scholar] [CrossRef] [PubMed]
- Ohmori, H.; Fujii, K.; Kadochi, Y.; Mori, S.; Nishiguchi, Y.; Fujiwara, R.; Kishi, S.; Sasaki, T.; Kuniyasu, H. Elaidic acid, a trans-fatty acid, enhances the metastasis of colorectal cancer cells. Pathobiology 2017, 84, 144–151. [Google Scholar] [CrossRef] [PubMed]
- Granados, N.; Amengual, J.; Ribot, J.; Palou, A.; Bonet, M.L. Distinct effects of oleic acid and its trans-isomer elaidic acid on the expression of myokines and adipokines in cell models. Br. J. Nutr. 2011, 105, 1226–1234. [Google Scholar] [CrossRef]
- Bimenyindavyi, E.; Timofeeva, O.A. Phenolics and ascorbic contents in two sage (Salvia sps. L) species. J. Exp. Biol. Agric. Sci. 2020, 8, 286–291. [Google Scholar] [CrossRef]
- Smirnoff, N.; Wheeler, G.L. The ascorbate biosynthesis pathway in plants is known, but there is a way to go with understanding control and functions. J. Exp. Bot. 2024, 75, 2604–2630. [Google Scholar] [CrossRef] [PubMed]
- Afonso, A.F.; Pereira, O.R.; Cardoso, S.M. Salvia species as nutraceuticals: Focus on antioxidant, antidiabetic and anti-obesity properties. Appl. Sci. 2021, 11, 9365. [Google Scholar] [CrossRef]
- May, J.M.; Harrison, F.E. Role of vitamin C in the function of the vascular endothelium. Antioxid. Redox Signal. 2013, 19, 2068–2083. [Google Scholar] [CrossRef] [PubMed]
- Orywal, K.; Socha, K.; Iwaniuk, P.; Kaczyński, P.; Farhan, J.A.; Zoń, W.; Łozowicka, B.; Perkowski, M.; Mroczko, B. Vitamins in the prevention and support therapy of neurodegenerative diseases. Int. J. Mol. Sci. 2025, 26, 1333. [Google Scholar] [CrossRef]
- Kocot, J.; Luchowska-Kocot, D.; Kiełczykowska, M.; Musik, I.; Kurzepa, J. Does Vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients 2017, 9, 659. [Google Scholar] [CrossRef] [PubMed]
- Rai, S.N.; Singh, P.; Steinbusch, H.W.M.; Vamanu, E.; Ashraf, G.; Singh, M.P. The role of vitamins in neurodegenerative disease: An update. Biomedicines 2021, 9, 1284. [Google Scholar] [CrossRef]
- Kumar, R.R.; Singh, L.; Thakur, A.; Singh, S.; Kumar, B. Role of vitamins in neurodegenerative diseases: A review. CNS Neurol. Disord. Drug Targets 2022, 21, 766–773. [Google Scholar] [CrossRef]
- Carr, A.C.; McCall, C. The role of vitamin C in the treatment of pain: New insights. J. Transl. Med. 2017, 15, 77. [Google Scholar] [CrossRef]
- Jafari, D.; Esmaeilzadeh, A.; Mohammadi-Kordkhayli, M.; Rezaei, N. Vitamin C and the immune system. In Nutrition and Immunity, 1st ed.; Mahmoudi, M., Rezaei, N., Eds.; Chapter 4; Springer: Cham, Switzerland, 2019; pp. 81–102. [Google Scholar] [CrossRef]
- Suebsaard, P.; Charerntantanakul, W. Rutin, α-tocopherol, and l-ascorbic acid up-regulate type I interferon-regulated gene and type I and II interferon expressions and reduce inflammatory cytokine expressions in monocyte-derived macrophages infected with highly pathogenic porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2021, 235, 110231. [Google Scholar] [CrossRef]
- Moazzen, A.; Öztinen, N.; Ak-Sakalli, E.; Koşar, M. Structure-antiradical activity relationships of 25 natural antioxidant phenolic compounds from different classes. Heliyon 2022, 8, 10467. [Google Scholar] [CrossRef] [PubMed]
- Guo, L.; Duan, L.; Dong, X.; Dou, L.L.; Zhou, P.; Li, P.; Liu, E.H. Metabolic profile of miltirone in rats by high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2015, 107, 473–479. [Google Scholar] [CrossRef] [PubMed]
- Miraj, S.; Kiani, S. A review study of therapeutic effects of Salvia officinalis L. Pharm. Lett. 2016, 8, 299–303. [Google Scholar]
- Poulios, E.; Giaginis, C.; Vasios, G.K. Current state of the art on the antioxidant activity of sage (Salvia spp.) and its bioactive components. Planta Med. 2020, 86, 224–238. [Google Scholar] [CrossRef]
- Jean, W.H.; Huang, C.T.; Hsu, J.H.; Chiu, K.M.; Lee, M.Y.; Shieh, J.S.; Lin, T.Y.; Wang, S.J. Anticonvulsive and neuroprotective effects of eupafolin in rats are associated with the inhibition of glutamate overexcitation and upregulation of the Wnt/β-Catenin signaling pathway. ACS Chem. Neurosci. 2022, 13, 1594–1603. [Google Scholar] [CrossRef]
- Miura, K.; Kikuzaki, H.; Nakatani, N. Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method. J. Agric. Food Chem. 2002, 50, 1845–1851. [Google Scholar] [CrossRef]
- Mervić, M.; Bival Štefan, M.; Kindl, M.; Blažeković, B.; Marijan, M.; Vladimir-Knežević, S. Comparative antioxidant; anti-acetylcholinesterase and anti-α-glucosidase activities of Mediterranean Salvia species. Plants 2022, 11, 625. [Google Scholar] [CrossRef]
- Santos-Gomes, P.C.; Seabra, R.M.; Andrade, P.B.; Fernandes-Ferreira, M. Phenolic antioxidant compounds produced by in vitro shoots of sage (Salvia officinalis L.). Plant Sci. 2002, 162, 981–987. [Google Scholar] [CrossRef]
- Kan, Y.; Gökbulut, A.L.P.E.R.; Kartal, M.; Konuklugil, B.E.L.M.A.; Yılmaz, G. Development and validation of a LC method for the analysis of phenolic acids in Turkish Salvia species. Chromatographia 2007, 66, 147–152. [Google Scholar] [CrossRef]
- Farhat, M.B.; Landoulsi, A.; Chaouch-Hamada, R.; Sotomayor, J.A.; Jordán, M.J. Characterization and quantification of phenolic compounds and antioxidant properties of Salvia species growing in different habitats. Ind. Crop. Prod. 2013, 49, 904–914. [Google Scholar] [CrossRef]
- Habán, M.; Habánová, M.; Holovičová, M.; Ražná, K. Rosmarinic acid content in selected varieties of sage (Salvia officinalis L.). J. Cent. Eur. Agric. 2019, 20, 305–320. [Google Scholar] [CrossRef]
- Shekarchi, M.; Hajimehdipoor, H.; Saeidnia, S.; Gohari, A.R.; Hamedani, M.P. Comparative study of rosmarinic acid content in some plants of Labiatae family. Pharmacogn. Mag. 2012, 8, 37–41. [Google Scholar] [CrossRef]
- Onder, A.; Izgi, M.N.; Cinar, A.S.; Zengin, G.; Yilmaz, M.A. The characterization of phenolic compounds via LC-ESI-MS/MS, antioxidant, enzyme inhibitory activities of Salvia absconditiflora, Salvia sclarea, and Salvia palaestina: A comparative analysis. S. Afr. J. Bot. 2022, 150, 313–322. [Google Scholar] [CrossRef]
- Luo, C.; Zou, L.; Sun, H.; Peng, J.; Gao, C.; Bao, L.; Ji, R.; Jin, Y.; Sun, S. A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases. Front. Pharmacol. 2020, 11, 153. [Google Scholar] [CrossRef]
- Dahchour, A. Anxiolytic and antidepressive potentials of rosmarinic acid: A review with a focus on antioxidant and anti-inflammatory effects. Pharmacol. Res. 2022, 184, 106421. [Google Scholar] [CrossRef] [PubMed]
- Noor, S.; Mohammad, T.; Rub, M.A.; Raza, A.; Azum, N.; Yadav, D.K.; Hassan, M.I.; Asiri, A.M. Biomedical features and therapeutic potential of rosmarinic acid. Arch. Pharm. Res. 2022, 45, 205–228. [Google Scholar] [CrossRef]
- Pizani, R.S.; Viganó, J.; de Souza Mesquita, L.M.; Contieri, L.S.; Sanches, V.L.; Chaves, J.O.; Souza, M.C.; da Silva, L.C.; Rostagno, M.A. Beyond aroma: A review on advanced extraction processes from rosemary (Rosmarinus officinalis) and sage (Salvia officinalis) to produce phenolic acids and diterpenes. Trends Food Sci. Technol. 2022, 127, 245–262. [Google Scholar] [CrossRef]
- Duran, R.E. In vitro callus culture of Salvia officinalis L. and the effect of some amino acids on rosmarinic acid accumulation. Osman. Korkut Ata Üniv. Fen Biliml. Enstitüsü Derg. 2024, 7, 1970–1981. [Google Scholar] [CrossRef]
- Amer, A.A.; Kassem, S.H.; Hussein, M.A. Chemical composition, antioxidant, cytotoxic, antiviral, and lung-protective activities of Salvia officinalis L. ethanol extract herb growing in Sinai, Egypt. Beni-Suef Univ. J. Basic. Appl. Sci. 2024, 13, 39. [Google Scholar] [CrossRef]
- Pavić, V.; Jakovljević, M.; Molnar, M.; Jokić, S. Extraction of carnosic acid and carnosol from sage (Salvia officinalis L.) leaves by supercritical fluid extraction and their antioxidant and antibacterial activity. Plants 2019, 8, 16. [Google Scholar] [CrossRef]
- Mokhtari, R.; Kazemi Fard, M.; Rezaei, M.; Moftakharzadeh, S.A.; Mohseni, A. Antioxidant, antimicrobial activities, and characterization of phenolic compounds of thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and thyme–sage mixture extracts. J. Food Qual. 2023, 2023, 2602454. [Google Scholar] [CrossRef]
- Boufadi, M.Y.; Keddari, S.; Moulai-Hacene, F.; Sara, C.H.A.A. Chemical composition, antioxidant and anti-inflammatory properties of Salvia officinalis extract from Algeria. Pharmacogn. J. 2021, 13, 506–515. [Google Scholar] [CrossRef]
- Margetts, G.; Kleidonas, S.; Zaibi, N.S.; Zaibi, M.S.; Edwards, K.D. Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L. BMC Complement. Med. Ther. 2022, 22, 131. [Google Scholar] [CrossRef]
- Mahdizadeh, R.; Moein, S.; Soltani, N.; Malekzadeh, K.; Mahmoodreza, M. Study the molecular mechanism of Salvia species in prevention of diabetes. Int. J. Pharm. Sci. Res. 2018, 9, 4512–4521. [Google Scholar] [CrossRef]
- Adımcılar, V.; Kalaycıoğlu, Z.; Aydoğdu, N.; Dirmenci, T.; Kahraman, A.; Erim, F.B. Rosmarinic and carnosic acid contents and correlated antioxidant and antidiabetic activities of 14 Salvia species from Anatolia. J. Pharm. Biomed. Anal. 2019, 175, 112763. [Google Scholar] [CrossRef]
- Rashed, A.A.; Rathi, D.N.G. Bioactive components of Salvia and their potential antidiabetic properties: A review. Molecules 2021, 26, 3042. [Google Scholar] [CrossRef] [PubMed]
- Bahri, S.; Mies, F.; Ben Ali, R.; Mlika, M.; Jameleddine, S.; Mc Entee, K.; Shlyonsky, V. Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts. PLoS ONE 2017, 12, 0184368. [Google Scholar] [CrossRef]
- Irtegun Kandemir, S.; Fidan, H.S.; Yener, I.; Mete, N.; Ertas, A.; Topcu, G.; Kolak, U. Investigation of cytotoxic and apoptotic effects of 63 compounds obtained from Salvia species: Promising anticancer agents. J. Food Biochem. 2022, 46, 14226. [Google Scholar] [CrossRef] [PubMed]
- Brindisi, M.; Bouzidi, C.; Frattaruolo, L.; Loizzo, M.R.; Tundis, R.; Dugay, A.; Deguin, B.; Cappello, A.R.; Cappello, M.S. Chemical profile, antioxidant, anti-inflammatory, and anti-cancer effects of Italian Salvia rosmarinus Spenn. methanol leaves extracts. Antioxidants 2020, 9, 826. [Google Scholar] [CrossRef]
- Oliveira, C.S.; Barbosa, F.L.; Ehrenfried, C.A.; Rodrigues, T.E.B.; Salvador, M.J.; Zampronio, A.R.; Stefanello, M.É.A. Chemical constituents and anti-inflammatory, antinociceptive, and antioxidant activities of Salvia melissiflora aerial parts. Rev. Bras. Farmacogn. 2024, 34, 350–357. [Google Scholar] [CrossRef]
- Elufioye, T.O.; Habtemariam, S. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomed. Pharmacother. 2019, 112, 108600. [Google Scholar] [CrossRef]
- Ayoub, I.M.; George, M.Y.; Menze, E.T.; Mahmoud, M.; Botros, M.; Essam, M.; Ashmawy, I.; Shendi, P.; Hany, A.; Galal, M.; et al. Insights into the neuroprotective effects of Salvia officinalis L. and Salvia microphylla Kunth in the memory impairment rat model. Food Funct. 2022, 13, 2253–2268. [Google Scholar] [CrossRef]
- Faridzadeh, A.; Salimi, Y.; Ghasemirad, H.; Kargar, M.; Rashtchian, A.; Mahmoudvand, G.; Karimi, M.A.; Zerangian, N.; Jahani, N.; Masoudi, A.; et al. Neuroprotective potential of aromatic herbs: Rosemary, sage, and lavender. Front. Neurosci. 2022, 16, 909833. [Google Scholar] [CrossRef]
- Abdelmoez, A.; Raslan, H.; Hassan, N.; Zahran, A.; Hussein, A.M. Evaluation of Salvia rosmarinus and Coriandrum sativum as chemopreventive agents in induced oral squamous cell carcinoma (an experimental study). Alex. Dental J. 2025, 50, 108–114. [Google Scholar] [CrossRef]
- Russo, A.; Formisano, C.; Rigano, D.; Senatore, F.; Delfine, S.; Cardile, V.; Sergio Rosselli, S.; Bruno, M. Chemical composition and anticancer activity of essential oils of Mediterranean sage (Salvia officinalis L.) grown in different environmental conditions. Food Chem. Toxicol. 2013, 55, 42–47. [Google Scholar] [CrossRef]
- Zhao, J.; Xu, L.; Jin, D.; Xin, Y.; Tian, L.; Wang, T.; Zhao, D.; Wang, Z.; Wang, J. Rosmarinic acid and related dietary supplements: Potential applications in the prevention and treatment of cancer. Biomolecules 2022, 12, 1410. [Google Scholar] [CrossRef] [PubMed]
- Musolino, V.; Macrì, R.; Cardamone, A.; Tucci, L.; Serra, M.; Lupia, C.; Maurotti, S.; Mare, R.; Nucera, S.; Guarnieri, L.; et al. Salvia rosmarinus spenn. (Lamiaceae) hydroalcoholic extract: Phytochemical analysis, antioxidant activity and in vitro evaluation of fatty acid accumulation. Plants 2023, 12, 3306. [Google Scholar] [CrossRef] [PubMed]
- Baptista, A.; Menicucci, F.; Brunetti, C.; dos Santos Nascimento, L.B.; Pasquini, D.; Alderotti, F.; Detti, C.; Ferrini, F.; Gori, A. Unlocking the hidden potential of rosemary (Salvia rosmarinus Schleid): New insights into phenolics, terpenes, and antioxidants of Mediterranean cultivars. Plants 2024, 13, 3395. [Google Scholar] [CrossRef]
- Hashempour, H.; Abedi-Ghobadloo, P. Screening of Salvia L. species from Iran for antioxidant activity and evaluation of rosmarinic acid content to meet highly active extract. J. Med. Plants By-Prod. 2024, 13, 1118–1128. [Google Scholar] [CrossRef]
- Ding, Y.; Ma, T.; Zhang, Y.; Zhao, C.; Wang, C.; Wang, Z. Rosmarinic acid ameliorates skin inflammation and pruritus in allergic contact dermatitis by inhibiting mast cell-mediated MRGPRX2/PLCγ1 signaling pathway. Int. Immunopharmacol. 2023, 117, 110003. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.; Jung, E.; Koh, J.; Kim, Y.S.; Park, D. Effect of rosmarinic acid on atopic dermatitis. J. Dermatol. 2008, 35, 768–771. [Google Scholar] [CrossRef]
- Shim, K.S.; Kim, H.J.; Ji, K.Y.; Jung, D.H.; Park, S.H.; Song, H.K.; Kim, T.; Kim, K.M. Rosmarinic acid ameliorates dermatophagoides farinae extract-induced atopic dermatitis-like skin inflammation by activating the Nrf2/HO-1 signaling pathway. Int. J. Mol. Sci. 2024, 25, 12737. [Google Scholar] [CrossRef] [PubMed]
- Kowalczyk, A.; Tuberoso, C.I.G.; Jerković, I. The role of rosmarinic acid in cancer prevention and therapy: Mechanisms of antioxidant and anticancer activity. Antioxidants 2024, 13, 1313. [Google Scholar] [CrossRef]
- Zengin, G.; Senkardes, I.; Mollica, A.; Picot-Allain, C.M.N.; Bulut, G.; Dogan, A.; Mahomoodally, M.F. New insights into the in vitro biological effects, in silico docking and chemical profile of clary sage—Salvia sclarea L. Comput. Biol. Chem. 2018, 75, 111–119. [Google Scholar] [CrossRef]
- Hanganu, D.; Olah, N.K.; Pop, C.E.; Vlase, L.; Oniga, I.; Ciocarlan, N.; Matei, A.; Puşcaş, C.M.; Silaghi-Dumitrescu, R.; Benedec, D. Evaluation of polyphenolic profile and antioxidant activity for some Salvia species. Farmacia 2019, 67, 801–805. [Google Scholar] [CrossRef]
- Mao, J.L.; Wang, L.; Chen, S.J.; Yan, B.; Xun, L.Y.; Li, R.C.; Wang, P.C.; Zhao, Q.T. Design, synthesis, antiviral activities of ferulic acid derivatives. Front. Pharmacol. 2023, 14, 1133655. [Google Scholar] [CrossRef]
- Verzola, M.M.S.A.; de Almeida Marques, D.P.; da Silva, E.B.; Serafim, M.S.M.; Ferreira, R.S.; Fajtová, P.; Kohlhoff, M.; O’Donoghue, A.J.; Maltarollo, V.G.; Coelho-dos-Reis, J.G.A.; et al. Synthesis of indole-based ferulic acid derivatives and in vitro evaluation of antiviral activity against SARS-CoV-2. Med. Chem. Res. 2023, 32, 2256–2267. [Google Scholar] [CrossRef]
- Wijayanti, E.D.; Safitri, A.; Siswanto, D.; Triprisila, L.F.; Fatchiyah, F. Antimicrobial activity of ferulic acid in Indonesian purple rice through toll-like receptor signaling. Makara J. Sci. 2021, 25, 247–257. [Google Scholar] [CrossRef]
- De Morais, M.C.; Perez-Castillo, Y.; Silva, V.R.; de Souza Santos, L.; Soares, M.B.P.; Bezerra, D.P.; de Castro, R.D.; de Sousa, D.P. Cytotoxic and antifungal amides derived from ferulic acid: Molecular docking and mechanism of action. Biomed. Res. Int. 2021, 2021, 3598000. [Google Scholar] [CrossRef] [PubMed]
- Peres, D.D.A.; Sarruf, F.D.; de Oliveira, C.A.; Velasco, M.V.R.; Baby, A.R. Ferulic acid photoprotective properties in association with UV filters: Multifunctional sunscreen with improved SPF and UVA-PF. J. Photochem. Photobiol. B 2018, 185, 46–49. [Google Scholar] [CrossRef] [PubMed]
- Dubey, A.; Sharma, A.; Verma, S. Ferulic acid surface modified silica polymer nanocomposites (SMS/FA) for antioxidant and antifungal activities. Mater. Today Proc. 2020, 26, 3003–3008. [Google Scholar] [CrossRef]
- Larionov, E.A.; Larionova, V.M.; Kozlova, E.M. A UV spectroscopic study of the photoprotective properties of troxerutin, ferulic acid, and aqueous extracts of Melissa officinalis and Mentha piperita. Russ. J. Appl. Chem. 2022, 95, 1823–1828. [Google Scholar] [CrossRef]
- Alam, M.A. Anti-hypertensive effect of cereal antioxidant ferulic acid and its mechanism of action. Front. Nutr. 2019, 6, 121. [Google Scholar] [CrossRef]
- Mancuso, A.; Cristiano, M.C.; Pandolfo, R.; Greco, M.; Fresta, M.; Paolino, D. Improvement of ferulic acid antioxidant activity by multiple emulsions: In vitro and in vivo evaluation. Nanomaterials 2021, 11, 425. [Google Scholar] [CrossRef]
- Zhou, Z.; Shi, T.; Hou, J.; Li, M. Ferulic acid alleviates atopic dermatitis-like symptoms in mice via its potent anti-inflammatory effect. Immunopharmacol. Immunotoxicol. 2020, 42, 156–164. [Google Scholar] [CrossRef]
- Liu, Y.; Shi, L.; Qiu, W.; Shi, Y. Ferulic acid exhibits anti-inflammatory effects by inducing autophagy and blocking NLRP3 inflammasome activation. Mol. Cell. Toxicol. 2022, 18, 509–519. [Google Scholar] [CrossRef]
- Cavalcanti, G.R.; Duarte, F.I.; Converti, A.; de Lima, Á.A. Activity in topical formulations: Technological and scientific prospecting. Curr. Pharm. Des. 2021, 27, 2289–2298. [Google Scholar] [CrossRef] [PubMed]
- Dragan, M.; Stan, C.D.; Iacob, A.T.; Dragostin, O.; Profire, L. Ferulic acid: Potential therapeutic applications. Rev. Med. Chir. Soc. Med. Nat. Iaşi. 2018, 122, 388–395. [Google Scholar]
- Raj, N.D.; Singh, D. A critical appraisal on ferulic acid: Biological profile, biopharmaceutical challenges and nano formulations. Health Sci. Rev. 2022, 5, 100063. [Google Scholar] [CrossRef]
- DiNicolantonio, J.J.; McCarty, M.F.; Assanga, S.I.; Lujan, L.L.; O’Keefe, J.H. Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity. Open Heart 2022, 9, 001801. [Google Scholar] [CrossRef] [PubMed]
- Arınmış, K.N.; Kıyan, H.T.; Ozturk, A.A. Preparation, characterization, antioxidant activities, and determination of anti-Alzheimer effects of PLGA-based DDSs containing ferulic acid. ACS Omega 2024, 9, 11321–11338. [Google Scholar] [CrossRef]
- Khatun, M.M.; Bhuia, M.S.; Chowdhury, R.; Sheikh, S.; Ajmee, A.; Mollah, F.; Hasan, M.S.A.; Coutinho, H.D.M.; Islam, M.T. Potential utilization of ferulic acid and its derivatives in the management of metabolic diseases and disorders: An insight into mechanisms. Cell. Signal. 2024, 121, 111291. [Google Scholar] [CrossRef]
- Singh, G.; Kumar, S.; Panda, S.R.; Kumar, P.; Rai, S.; Verma, H.; Singh, Y.P.; Kumar, S.; Srikrishna, S.; Naidu, V.G.M.; et al. Design, synthesis, and biological evaluation of ferulic acid-piperazine derivatives targeting pathological hallmarks of Alzheimer’s disease. ACS Chem. Neurosci. 2024, 15, 2756–2778. [Google Scholar] [CrossRef]
- Ahmad, M.F.; Aziz, T.; Naseem, N.; Shadab, G.H.A.; Ahsan, H.; Younus, H.; Ola, M.S.; Siddiqui, W.A. Beneficial effects of ferulic acid in streptozotocin-induced diabetic neuropathy in male Wistar rats. Nutrire 2024, 49, 8. [Google Scholar] [CrossRef]
- Kumar, M.; Kaushik, D.; Shubham, S.; Kumar, A.; Kumar, V.; Oz, E.; Brennan, C.; Zeng, M.; Proestos, C.; Çadırcı, K.; et al. Ferulic acid: Extraction, estimation, bioactivity and applications for human health and food. J. Sci. Food Agric. 2024, 105, 4168–4177. [Google Scholar] [CrossRef] [PubMed]
- Singh, S.S.B.; Patil, K.N. SIRT1/AMPK-mediated pathway: Ferulic acid from sugar beet pulp mitigating obesity-induced diabetes-linked complications and improving metabolic health. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2024, 1869, 159511. [Google Scholar] [CrossRef]
- Gu, Y.; Zhang, Y.; Li, M.; Huang, Z.; Jiang, J.; Chen, Y.; Chen, J.; Jia, Y.; Zhang, L.; Zhou, F. Ferulic acid ameliorates atherosclerotic injury by modulating gut microbiota and lipid metabolism. Front. Pharmacol. 2021, 12, 621339. [Google Scholar] [CrossRef] [PubMed]
- Hong, K.; Wang, J.; Kang, X.; Xue, H.; Gao, Y.; Liang, H.; Huang, W.; Zhan, J.; You, Y. Ferulic acid and protocatechuic acid alleviate atherosclerosis by promoting UCP1 expression to inhibit the NLRP3-IL-1β signaling pathway. Food Funct. 2025, 16, 40–53. [Google Scholar] [CrossRef]
- Zhao, Y.; Wang, H.; Zhao, J.; Wang, X.; Wang, Y.; Li, W.; Song, T.; Hao, G.; Fu, X.; Gu, X. Renal protective effect of sodium ferulate on pulmonary hypertension patients undergoing computed tomography pulmonary angiography. Pulm. Circ. 2020, 10, 2045894020903953. [Google Scholar] [CrossRef]
- Bao, X.; Li, W.; Jia, R.; Meng, D.; Zhang, H.; Xia, L. Molecular mechanism of ferulic acid and its derivatives in tumor progression. Pharmacol. Rep. 2023, 75, 891–906. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Zhao, D.; Luan, C.; Zheng, J.; Liu, W.; Feng, Z.; Luo, R.; Han, X.; Wang, D. Ferulic acid induces autophagy and apoptosis in colon cancer CT26 cells via the MAPK pathway. Molecules 2023, 28, 6014. [Google Scholar] [CrossRef]
- Abdulal, Z.A.; Altahhan, M.Y.; Qindil, A.F.; Al-Juhani, A.M.; Alatawi, M.A.; Hassan, H.M.; Al-Gayyar, M.M. Ferulic acid inhibits tumor proliferation and attenuates inflammation of hepatic tissues in experimentally induced HCC in rats. J. Investig. Med. 2024, 72, 900–910. [Google Scholar] [CrossRef] [PubMed]
- Cha, S.; Kim, G.U.; Cha, J.D. Synergistic antimicrobial activity of apigenin against oral pathogens. Int. J. Eng. Res. Sci. 2016, 2, 27–37. [Google Scholar]
- Zhu, L.; Zhang, H.; Zhang, X.; Xia, L.; Zhang, J. Research progress on antisepsis effect of apigenin and its mechanism of action. Heliyon 2023, 9, 22290. [Google Scholar] [CrossRef]
- Selim, S.; Albqmi, M.; Alanazi, A.; Alruwaili, Y.; Al-Sanea, M.M.; Alnusaire, T.S.; Almuhayawi, M.S.; Jaouni, S.K.A.; Hussein, S.; Warrad, M.; et al. Antiviral activities of olive oil apigenin and taxifolin against SARS-CoV-2 RNA-dependent RNA polymerase (RdRP): In silico, pharmacokinetic, ADMET, and in-vitro approaches. Cogent. Food Agric. 2023, 9, 2236828. [Google Scholar] [CrossRef]
- Chatterjee, S.; Pyne, N.; Paul, S. In silico screening of flavonoids unearthed apigenin and epigallocatechin gallate, possessing antiviral potentiality against Delta and Omicron variants of SARS-CoV-2. Nucleus 2024, 67, 359–369. [Google Scholar] [CrossRef]
- Jaffer, N.T.; Hasan, R.M.A.; Taqa, G.A.A. Effects of apigenin and shell nano-additives on antifungal behaviour and roughness of the soft prosthesis lining. Cell. Mol. Biol. 2023, 69, 37–42. [Google Scholar] [CrossRef]
- Alghamdi, A.; Almuqbil, M.; Alrofaidi, M.A.; Burzangi, A.S.; Alshamrani, A.A.; Alzahrani, A.R.; Kamal, M.; Imran, M.; Alshehri, S.; Mannasaheb, B.A.; et al. Potential antioxidant activity of apigenin in the obviating stress-mediated depressive symptoms of experimental mice. Molecules 2022, 27, 9055. [Google Scholar] [CrossRef]
- Zafar, A.; Alruwaili, N.K.; Imam, S.S.; Alsaidan, O.A.; Ahmed, M.M.; Yasir, M.; Warsi, M.H.; Alquraini, A.; Ghoneim, M.M.; Alshehri, S. Development and optimization of hybrid polymeric nanoparticles of apigenin: Physicochemical characterization, antioxidant activity and cytotoxicity evaluation. Sensors 2022, 22, 1364. [Google Scholar] [CrossRef] [PubMed]
- Yoon, J.H.; Kim, M.Y.; Cho, J.Y. Apigenin: A therapeutic agent for treatment of skin inflammatory diseases and cancer. Int. J. Mol. Sci. 2023, 24, 1498. [Google Scholar] [CrossRef] [PubMed]
- Alamri, Z.Z. Apigenin attenuates indomethacin-induced gastric ulcer in rats: Emphasis on antioxidant, anti-inflammatory, anti-apoptotic, and TGF-β1 enhancing activities. Naunyn. Schmiedebergs. Arch. Pharmacol. 2024, 397, 8803–8814. [Google Scholar] [CrossRef]
- Olasehinde, T.A.; Olaokun, O.O. Apigenin and inflammation in the brain: Can apigenin inhibit neuroinflammation in preclinical models? Inflammopharmacology 2024, 32, 3099–3108. [Google Scholar] [CrossRef] [PubMed]
- Sánchez-Marzo, N.; Pérez-Sánchez, A.; Ruiz-Torres, V.; Martínez-Tébar, A.; Castillo, J.; Herranz-López, M.; Barrajón-Catalán, E. Antioxidant and photoprotective activity of apigenin and its potassium salt derivative in human keratinocytes and absorption in Caco-2 cell monolayers. Int. J. Mol. Sci. 2019, 20, 2148. [Google Scholar] [CrossRef]
- Monadi, T.; Mohajer, Z.; Soltani, A.; Khazeei Tabari, M.A.; Manayi, A.; Azadbakht, M. The influence of apigenin on cellular responses to radiation: From protection to sensitization. BioFactors 2025, 51, 2113. [Google Scholar] [CrossRef]
- Lorusso, F.; Scarano, A.; Fulle, S.; Valbonetti, L.; Mancinelli, R.; Di Filippo, E.S. Effectiveness of apigenin, resveratrol, and curcumin as adjuvant nutraceuticals for calvarial bone defect healing: An in vitro and histological study on rats. Nutrients 2023, 15, 1235. [Google Scholar] [CrossRef]
- Li, K.; Wu, L.; Jiang, J. Apigenin accelerates wound healing in diabetic mice by promoting macrophage M2-type polarization via increasing miR-21 expression. Mol. Cell. Biochem. 2024, 479, 3119–3127. [Google Scholar] [CrossRef]
- Sreekumar, S.; Vijayan, V.; Gangaraj, K.P.; Kiran, M.S. Apigenin self-assembled collagen biomatrix for reprogramming the obese wound microenvironment for its management and repair. ACS Appl. Bio Mater. 2024, 7, 1317–1335. [Google Scholar] [CrossRef] [PubMed]
- Medhat, A.M.; Azab, K.S.; Said, M.M.; El Fatih, N.M.; El Bakary, N.M. Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice. Tumor Biol. 2017, 39, 1010428317728480. [Google Scholar] [CrossRef]
- Oh, H.M.; Cho, C.K.; Lee, N.H.; Son, C.G. Experimental evidence for anti-metastatic actions of apigenin: A mini review. Front. Oncol. 2024, 14, 1380194. [Google Scholar] [CrossRef]
- Das, S.; Das, J.; Samadder, A.; Boujedaini, N.; Khuda-Bukhsh, A.R. Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria. Exp. Biol. Med. 2012, 237, 1433–1448. [Google Scholar] [CrossRef] [PubMed]
- Ghițu, A.; Schwiebs, A.; Radeke, H.H.; Avram, S.; Zupko, I.; Bor, A.; Pavel, I.Z.; Dehelean, C.A.; Oprean, C.; Bojin, F.; et al. A comprehensive assessment of apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound. Nutrients 2019, 11, 858. [Google Scholar] [CrossRef]
- Noorian, M.; Chamani, E.; Salmani, F.; Rezaei, Z.; Khorsandi, K. Effects of doxorubicin and apigenin on chronic myeloid leukemia cells (K562) in vitro: Anti-proliferative and apoptosis induction assessments. Nat. Prod. Res. 2023, 37, 3335–3343. [Google Scholar] [CrossRef]
- Ma, Y.; Bao, M.; Peng, Y.; Gao, J.; Bao, J. Eco-friendly nanoparticles synthesized from Salvia sclarea ethanol extract protect against STZ-induced diabetic nephropathy in rats via antioxidant, anti-inflammatory, and apoptosis mechanisms. J. Oleo. Sci. 2024, 73, 1057–1067. [Google Scholar] [CrossRef]
- Fu, J.; Zeng, W.; Chen, M.; Huang, L.; Li, S.; Li, Z.; Pan, Q.; Lv, S.; Yang, X.; Wang, Y.; et al. Apigenin inhibits angiogenesis and tumor growth by suppressing HIF-1α expression in non-small cell lung cancer. Chem. Biol. Interact. 2022, 361, 109966. [Google Scholar] [CrossRef]
- Ghiƫu, A.; Pavel, I.Z.; Avram, S.; Kis, B.; Minda, D.; Dehelean, C.A.; Buda, V.; Folescu, R.; Danciu, C. An in vitro-in vivo evaluation of the antiproliferative and antiangiogenic effect of flavone apigenin against SK-MEL-24 human melanoma cell line. Anal. Cell. Pathol. 2021, 2021, 5552664. [Google Scholar] [CrossRef]
- Zhang, W.; Zhuang, X.; Wu, C.; Jin, Y.; Xing, J.; Hou, M.; Yang, W.; Feng, Q.; Wang, H. Apigenin inhibits tumor angiogenesis by hindering microvesicle biogenesis via ARHGEF1. Cancer Lett. 2024, 596, 216961. [Google Scholar] [CrossRef]
- Liu, X.; Zhao, T.; Shi, Z.; Hu, C.; Li, Q.; Sun, C. Synergism antiproliferative effects of apigenin and naringenin in NSCLC cells. Molecules 2023, 28, 4947. [Google Scholar] [CrossRef] [PubMed]
- Kasiri, N.; Ghannadian, S.M.; Hosseini, R.; Ahmadi, L.; Rahmati, M.; Ashtari, F.; Pourazar, A.; Eskandari, N. comparative analysis of apigenin-3 acetate versus apigenin and methyl-prednisolone in inhibiting proliferation and gene expression of Th1 cells in multiple sclerosis. Cell J. 2023, 25, 307–316. [Google Scholar] [CrossRef]
- Samir, A.; Abdeltawab, R.; Stein, U.; Thabit, S.; El Tayebi, H.M. 42P Apigenin: An immunomodulatory nutraceutical overriding PD-L1 inhibitors by halting AKT/mTOR pathway in triple-negative breast cancer (TNBC). ESMO Open 2023, 8, 101008. [Google Scholar] [CrossRef]
- dos Santos, C.C.; Carreira, R.B.; Dourado, N.S.; de Araújo, F.M.; de Almeida, M.M.A.; de Souza, V.M.; Soares, J.R.P.; do Nascimento, R.P.; de Oliveira, J.V.R.; Victor, M.M.; et al. Neuroprotection induced by apigenin. In Natural Molecules in Neuroprotection and Neurotoxicity, 1st ed.; de Oliveira, M.R., Ed.; Academic Press: Cambridge, MA, USA, 2024; pp. 1241–1262. [Google Scholar] [CrossRef]
- Wasim, M.; Zia, S.R.; Ahmad, S. Molecular docking analysis reveals the promising role of apigenin as a potential treatment for neurological disorders. Clin. Neuropharmacol. 2024, 47, 176–180. [Google Scholar] [CrossRef]
- Barky, A.; Ezz, A.; Mohammed, T. The potential role of apigenin in diabetes mellitus. Int. J. Clin. Case Rep. Rev. 2020, 3, 32. [Google Scholar]
- Miao, L.; Zhang, H.; Cheong, M.S.; Zhong, R.; Garcia-Oliveira, P.; Prieto, M.A.; Cheng, K.W.; Wang, M.; Cao, H.; Nie, S.; et al. Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells. Food Sci. Hum. Wellness 2023, 12, 1991–2000. [Google Scholar] [CrossRef]
- Qadi, H.H.; Bendary, M.A.; Almaghrabi, S.Y.; Zaher, M.A.F.; Karami, M.M.; Alsehli, A.M.; Babateen, O.; Arbaeen, A.F.; Burzangi, A.S.; Bazuhair, M.A. Exploring the therapeutic potential of apigenin in obesity-associated fibrinolytic dysfunction: Insights from an animal study. Cureus 2023, 15, 40943. [Google Scholar] [CrossRef]
- Hsu, M.C.; Chen, C.H.; Wang, M.C.; Chen, W.H.; Hu, P.A.; Guo, B.C.; Chang, R.W.; Wang, C.H.; Lee, T.S. Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance. Int. J. Biol. Sci. 2024, 20, 1563–1577. [Google Scholar] [CrossRef]
- Thomas, S.D.; Jha, N.K.; Jha, S.K.; Sadek, B.; Ojha, S. Pharmacological and molecular insight on the cardioprotective role of apigenin. Nutrients 2023, 15, 385. [Google Scholar] [CrossRef] [PubMed]
- Tomou, E.M.; Papakyriakopoulou, P.; Skaltsa, H.; Valsami, G.; Kadoglou, N.P. Bio-actives from natural products with potential cardioprotective properties: Isolation, identification, and pharmacological actions of apigenin, quercetin, and silibinin. Molecules 2023, 28, 2387. [Google Scholar] [CrossRef] [PubMed]
- Sharifiaghdam, Z.; Amini, S.M.; Dalouchi, F.; Behrooz, A.B.; Azizi, Y. Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis. Heliyon 2023, 9, 14024. [Google Scholar] [CrossRef]
- Al-Yamani, M.J.; Asdaq, S.M.B.; Alamri, A.S.; Alsanie, W.F.; Alhomrani, M.; Alsalman, A.J.; Mohaini, M.A.; Hawaj, M.A.A.; Alanazi, A.A.; Alanzi, K.D.; et al. The role of serotonergic and catecholaminergic systems for possible antidepressant activity of apigenin. Saudi J. Biol. Sci. 2022, 29, 11–17. [Google Scholar] [CrossRef]
- Amin, F.; Ibrahim, M.A.A.; Rizwan-ul-Hasan, S.; Khaliq, S.; Gabr, G.A.; Muhammad Khan, A.; Sidhom, P.A.; Tikmani, P.; Shawky, A.M.; Ahmad, S.; et al. Interactions of apigenin and safranal with the 5HT1A and 5HT2A receptors and behavioral effects in depression and anxiety: A molecular docking, lipid-mediated molecular dynamics, and in vivo analysis. Molecules 2022, 27, 8658. [Google Scholar] [CrossRef] [PubMed]
- Alizadeh, A.; Pourfallah-Taft, Y.; Khoshnazar, M.; Safdari, A.; Komari, S.V.; Zanganeh, M.; Sami, N.; Valizadeh, M.; Faridzadeh, A.; Alijanzadeh, D.; et al. Flavonoids against depression: A comprehensive review of literature. Front. Pharmacol. 2024, 15, 1411168. [Google Scholar] [CrossRef]
- Kramer, D.J.; Johnson, A.A. Apigenin: A natural molecule at the intersection of sleep and aging. Front. Nutr. 2024, 11, 1359176. [Google Scholar] [CrossRef] [PubMed]
- Qi, S.; Li, Z.; Bai, L.; Yuan, K.; Sun, S.; Ye, J.; Wang, M. Effect of apigenin on learning and memory ability of senile dementia mice. Rev. Cient. Fac. Cienc. Vet. 2020, 30, 2573–2581. [Google Scholar]
- Allemailem, K.S.; Almatroudi, A.; Alharbi, H.O.A.; AlSuhaymi, N.; Alsugoor, M.H.; Aldakheel, F.M.; Khan, A.A.; Rahmani, A.H. Apigenin: A bioflavonoid with a promising role in disease prevention and treatment. Biomedicines 2024, 12, 1353. [Google Scholar] [CrossRef]
- Gaur, K.; Siddique, Y.H. Effect of apigenin on neurodegenerative diseases. CNS Neurol. Disord. Drug. Targets 2024, 23, 468–475. [Google Scholar] [CrossRef]
- Generalić, I.; Skroza, D.; Šurjak, J.; Možina, S.S.; Ljubenkov, I.; Katalinić, A.; Simat, V.; Katalinić, V. Seasonal variations of phenolic compounds and biological properties in sage (Salvia officinalis L.). Chem. Biodivers. 2012, 9, 441–457. [Google Scholar] [CrossRef]
- Kharazian, N. Identification of flavonoids in leaves of seven wild growing Salvia L. (Lamiaceae) species from Iran. Prog. Biol. Sci. 2013, 3, 81–98. [Google Scholar] [CrossRef]
- Sharma, N.; Biswas, S.; Al-Dayan, N.; Alhegaili, A.S.; Sarwat, M. Antioxidant role of kaempferol in prevention of hepatocellular carcinoma. Antioxidants 2021, 10, 1419. [Google Scholar] [CrossRef]
- Alrumaihi, F.; Almatroodi, S.A.; Alharbi, H.O.A.; Alwanian, W.M.; Alharbi, F.A.; Almatroudi, A.; Rahmani, A.H. Pharmacological potential of kaempferol, a flavonoid in the management of pathogenesis via modulation of inflammation and other biological activities. Molecules 2024, 29, 2007. [Google Scholar] [CrossRef] [PubMed]
- Escandón, R.A.; Del Campo, M.; López-Solis, R.; Obreque-Slier, E.; Toledo, H. Antibacterial effect of kaempferol and (−)-epicatechin on Helicobacter pylori. Eur. Food Res. Technol. 2016, 242, 1495–1502. [Google Scholar] [CrossRef]
- Gao, L.; Tang, Z.; Li, T.; Wang, J. Combination of kaempferol and azithromycin attenuates Staphylococcus aureus-induced osteomyelitis via anti-biofilm effects and by inhibiting the phosphorylation of ERK1/2 and SAPK. Pathog. Dis. 2021, 79, ftab048. [Google Scholar] [CrossRef]
- Shao, J.; Zhang, M.; Wang, T.; Li, Y.; Wang, C. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans. Pharm. Biol. 2016, 54, 984–992. [Google Scholar] [CrossRef]
- Argüello-García, R.; Calzada, F.; García-Hernández, N.; Chávez-Munguía, B.; Velázquez-Domínguez, J.A. Ultrastructural and proapoptotic-like effects of kaempferol in Giardia duodenalis trophozoites and bioinformatics prediction of its potential protein target. Mem. Inst. Oswaldo Cruz 2020, 115, 200127. [Google Scholar] [CrossRef]
- Shahbaz, M.; Imran, M.; Alsagaby, S.A.; Naeem, H.; Al Abdulmonem, W.; Hussain, M.; Abdelgawad, M.A.; El-Ghorab, A.H.; Ghoneim, M.M.; El-Sherbiny, M.; et al. Anticancer, antioxidant, ameliorative and therapeutic properties of kaempferol. Int. J. Food Prop. 2023, 26, 1140–1166. [Google Scholar] [CrossRef]
- Alam, W.; Khan, H.; Shah, M.A.; Cauli, O.; Saso, L. Kaempferol as a dietary anti-inflammatory agent: Current therapeutic standing. Molecules 2020, 25, 4073. [Google Scholar] [CrossRef] [PubMed]
- Yeon, M.J.; Lee, M.H.; Kim, D.H.; Yang, J.Y.; Woo, H.J.; Kwon, H.J.; Moon, C.; Kim, S.H.; Kim, J.B. Anti-inflammatory effects of kaempferol on Helicobacter pylori—Induced inflammation. Biosci. Biotechnol. Biochem. 2019, 83, 166–173. [Google Scholar] [CrossRef]
- Liu, C.; Liu, H.; Lu, C.; Deng, J.; Yan, Y.; Chen, H.; Wang, Y.; Liang, C.L.; Wei, J.; Han, L.; et al. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin. Exp. Immunol. 2019, 198, 403–415. [Google Scholar] [CrossRef]
- Roby, M.H.H.; Sarhan, M.A.; Selim, K.A.H.; Khalel, K.I. Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind. Crops Prod. 2013, 43, 827–831. [Google Scholar] [CrossRef]
- Pero, R.W.; Lund, H.; Leanderson, T. Antioxidant metabolism induced by quinic acid. Increased urinary excretion of tryptophan and nicotinamide. Phytother. Res. 2009, 23, 335–346. [Google Scholar] [CrossRef]
- Ercan, L.; Doğru, M. Antioxidant and antimicrobial capacity of quinic acid. Bitlis Eren Üniversitesi Fen Bilim. Derg. 2022, 11, 1018–1025. [Google Scholar] [CrossRef]
- Benali, T.; Bakrim, S.; Ghchime, R.; Benkhaira, N.; El Omari, N.; Balahbib, A.; Taha, D.; Zengin, G.; Hasan, M.M.; Bibi, S.; et al. Pharmacological insights into the multifaceted biological properties of quinic acid. Biotechnol. Genet. Eng. Rev. 2024, 40, 3408–3437. [Google Scholar] [CrossRef]
- Wang, Y.; Wang, Y.; Zhao, T.; Li, M.; Wang, Y.; Cao, J.; Liu, Y.; Wang, Z.; Cheng, G. Protective effect of que zui tea on d-galactose-induced oxidative stress damage in mice via regulating SIRT1/Nrf2 signaling pathway. Molecules 2024, 29, 1384. [Google Scholar] [CrossRef]
- Park, Y.; Paing, Y.M.M.; Cho, N.; Kim, C.; Yoo, J.; Choi, J.W.; Lee, S.H. Quinic acid alleviates behavior impairment by reducing neuroinflammation and MAPK activation in LPS-treated mice. Biomol. Therap. 2024, 32, 309. [Google Scholar] [CrossRef]
- Li, S.; Cai, Y.; Guan, T.; Zhang, Y.; Huang, K.; Zhang, Z.; Cao, W.; Guan, X. Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites. Gut Microbes 2024, 16, 2374608. [Google Scholar] [CrossRef]
- Singh, A.; Chauhan, S.S.; Tripathi, V. Quinic acid attenuates oral cancer cell proliferation by downregulating cyclin D1 Expression and Akt signaling. Pharmacogn. Mag. 2018, 14, 14–19. [Google Scholar] [CrossRef]
- Zanello, P.R.; Koishi, A.C.; Rezende Júnior, C.d.O.; Oliveira, L.A.; Pereira, A.A.; de Almeida, M.V.; dos Santos, C.N.D.; Bordignon, J. Quinic acid derivatives inhibit dengue virus replication in vitro. Virol. J. 2015, 12, 223. [Google Scholar] [CrossRef]
- Calín-Sánchez, Á.; Lipan, L.; Cano-Lamadrid, M.; Kharaghani, A.; Masztalerz, K.; Carbonell-Barrachina, Á.A.; Figiel, A. Comparison of traditional and novel drying techniques and its effect on quality of fruits, vegetables and aromatic herbs. Foods 2020, 9, 1261. [Google Scholar] [CrossRef]
- Tan, C.H.; Hii, C.L. Guideline and selection of dryers for herbs, spices, and medicinal plants. In Drying of Herbs, Spices, and Medicinal Plants, 1st ed.; Hii, C.L., Shirkole, S.S., Eds.; Chapter 2; CRC Press: Boca Raton, FL, USA, 2023; pp. 11–28. [Google Scholar] [CrossRef]
- Nielsen, S.S. Determination of moisture content. In Food Analysis Laboratory Manual, 2nd ed.; Nielsen, S.S., Ed.; Chapter 3; Springer: New York, NY, USA, 2010; pp. 17–27. [Google Scholar] [CrossRef]
- Harris, G.K.; Marshall, M.R. Ash analysis. In Food Analysis; Nielsen, S.S., Ed.; Springer International Publishing: Cham, Switzerland, 2017; pp. 287–297. [Google Scholar] [CrossRef]
- Sáez-Plaza, P.; Michałowski, T.; Navas, M.J.; Asuero, A.G.; Wybraniec, S. An overview of the Kjeldahl method of nitrogen determination. Part I. Early history, chemistry of the procedure, and titrimetric finish. Crit. Rev. Anal. Chem. 2013, 43, 178–223. [Google Scholar] [CrossRef]
- Rabie, A.L.; Wells, J.D.; Dent, L.K. The nitrogen content of pollen protein. J. Apic. Res. 1983, 22, 119–123. [Google Scholar] [CrossRef]
- Davies, M.G.; Thomas, A.J. An investigation of hydrolytic techniques for the amino acid analysis of foodstuffs. J. Sci. Food Agric. 1973, 24, 1525–1540. [Google Scholar] [CrossRef]
- Anderson, S. Soxtec: Its principles and applications. In Oil Extraction and Analysis, 1st ed.; Andreson, S., Ed.; Chapter 2; Imprint AOCS Publishing: New York, NY, USA, 2019; pp. 11–24. [Google Scholar] [CrossRef]
- ISO 12966-1:2014; Animal and Vegetable Fats and Oils: Gas Chromatography of Fatty Acids Methyl Esters. Part 1. Guidelines on Modern Gas Chromatography of Fatty Acid Methyl Esters. ISO: Geneva, Switzerland, 2014.
- PN-EN 14130:2004; Foodstuffs—Determination of Vitamin C by HPLC. Polish Committee for Standardization: Warsaw, Poland, 2004.
- Singelton, V.L.; Rossi, J.A. Colorimetry of total phenolics with phosphomolybilic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar] [CrossRef]
- Lamaison, J.L.C.; Carnet, A. Teneurs en principaux flavonoids des fleurs de Crataegeus monogyna Jacq et de Crataegeus laevigata (Poiret D.C) en function de la vegetation. Pharm. Acta Helv. 1990, 65, 315–320. [Google Scholar]




















| Trivial Name | IUPAC Name: Systematic: | Abbreviation | Symbol | Molecular Formula | Linear Chemical Formula | Structural Chemical Formula |
|---|---|---|---|---|---|---|
| Arginine | (S)-2-Amino-5-guanidinopentanoic acid | Arg | R | C6H14N4O2 | HN=C(NH2)-NH-(CH2)3-CH(NH2)-COOH | ![]() |
| Phenylalanine | (2S)-2-amino-3-phenylpropanoic acid | Phe | F | C9H11NO2 | C6H5CH2CH(NH2)CO2H | ![]() |
| Histidine | (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid | His | H | C6H9N3O2 | NH-CH=N-CH=C-CH2-CH(NH2)-COOH | ![]() |
| Isoleucine | (2S,3S)-2-amino-3-methylpentanoic acid | Ile | I | C6H13NO2 | C2H5CH(CH3)CH(NH2)CO2H | ![]() |
| Leucine | (2S)-2-amino-4-methylpentanoic acid | Leu | L | C6H13NO2 | (CH3)2CHCH2CH(15NH2)CO2H | ![]() |
| Lysine | (2S)-2,6-diaminohexanoic acid | Lys | L | C6H14N2O2 | H2N-(CH2)4-CH(NH2)-COOH | ![]() |
| Threonine | (2S,3R)-2-amino-3-hydroxybutanoic acid | Thr | T | C4H9NO3 | CH3CH(OH)CH(15NH2)CO2H | ![]() |
| Valine | (2S)-2-amino-3-methylbutanoic acid | Val | V | C5H11NO2 | (CH3)2CHCH(NH2)CO2H | ![]() |
| Alanine | 2-aminopropanoic acid | Ala | A | C3H7NO2 | CH3CH(NH2)COOH | ![]() |
| Glycine | 2-Aminopropanoic acid | Gly | G | C2H5NO2 | NH2CH2COOH | ![]() |
| Aspartic acid | 2-Aminobutanedioic acid | Asp | D | C4H7NO4 | HO2CCH2CH(NH2)CO2H | ![]() |
| Glutamic acid | 2-Aminopentanedioic acid | Glu | E | C5H9NO4 | HO2CCH2CH2CH(NH2)CO2H | ![]() |
| Proline | Pyrrolidine-2-carboxylic acid | Pro | P | C5H9NO2 | HO2CCH(NH[CH2)3 | ![]() |
| Serine | (2S)-2-amino-3-hydroxypropanoic acid | Ser | S | C3H7NO3 | HOCH2CH(15NH2)CO2H | ![]() |
| Tyrosine | (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid | Tyr | Y | C9H11NO3 | 4-(OH)C6H4CH2CH(15NH2)CO2H | ![]() |
| Trivial Name | IUPAC Name: Systematic: | Abbreviation | Molecular Formula | Linear Chemical Formula | Structural Chemical Formula |
|---|---|---|---|---|---|
| Caproic acid | Hexanoic acid | C6:0 | C6H12O2 | CH3(CH2)4COOH | ![]() |
| Caprylic acid | Octanoic acid | C8:0 | C8H16O2 | CH3(CH2)6COOH | ![]() |
| Capric acid | Decanoic acid | C10:0 | C10H20O | CH3(CH2)8COOH | ![]() |
| Hendecanoic acid | Undecanoic acid | C11:0 | C11H22O2 | CH3(CH2)9COOH | ![]() |
| Lauric acid | Dodecanoic acid | C12:0 | C10H20O2 | CH3(CH2)10COOH | ![]() |
| Tridecylic acid | Tridecanoid acid | C13:0 | C13H26O | CH3(CH2)11CO2H | ![]() |
| Myristic acid | Tetradecanoic acid | C14:0 | C14H28O2 | CH3(CH2)12COOH | ![]() |
| Pentadecylic acid | Pentadecanoic acid | C15:0 | C15H30O2 | CH3(CH2)13COOH | ![]() |
| Palmitic acid | Hexadecanoic acid | C16:0 | C16H32O2 | CH3(CH2)14COOH | ![]() |
| Margaric acid | Heptadecanoic acid | C17:0 | C17H34O2 | CD3(CD2)14CD2COOH | ![]() |
| Stearic acid | Octadecanoic acid | C18:0 | C18H36O2 | CH3(CH2)16COOH | ![]() |
| Arachidic acid | Eicosanoic acid | C20:0 | C18H36O2 | CH3(CH2)18COOH | ![]() |
| Heneicosylic acid | Heneicosanoic acid | C21:0 | C21H42O2 | CH3(CH2)19COOH | ![]() |
| Behenic acid | Docosanoic acid | C22:0 | C22H44O2 | CH3(CH2)20COOH | ![]() |
| Tricosylic acid | Tricosanoic acid | C23:0 | C23H46O2 | CH3(CH2)21COOH | ![]() |
| Lignoceric acid | Tetracosanoic acid | C24:0 | C24H48O2 | CH3(CH2)22COOH | ![]() |
| Trivial Name | IUPAC Name: Systematic: | Abbreviation | Omega | Molecular Formula | Linear Chemical Formula | Structural Chemical Formula |
|---|---|---|---|---|---|---|
| Myristoleic acid | (9Z)-tetradec-9-enoic acid | C14:1n5 | Omega-5 | C14H26O2 | CH3(CH2)3CH=CH(CH2)7COOH | ![]() |
| cis-10-pentadecenoic acid | (10Z)-pentadec-10-enoic acid | C15:1n5 | Omega-5 | C15H28O2 | CH3(CH2)4CH=CH (CH2)8COOH | ![]() |
| Palmitoleic acid | (9Z)-hexadec-9-enoic acid | C16:1n7 | Omega-7 | C16H30O2 | CH3(CH2)5CH=CH(CH2)7COOH | ![]() |
| cis-10-heptadecenoic acid | (10Z)-heptadec-10-enoic acid | C17:1n7 | Omega-7 | C17H32O2 | CH3(CH2)15COOH | ![]() |
| Oleic acid | (9Z)-octadec-9-enoic acid | C18:1n9c | Omega-9 | C18H34O2 | CH3(CH2)7CH=CH(CH2)7COOH | ![]() |
| Elaidic acid | (9E)-octadec-9-enoic acid | C18:1n9t | Omega-9 | C18H34O2 | CH3(CH2)7CH=CH(CH2)7COOH | ![]() |
| cis-5-eicosenoic acid | (5Z)-eicos-5-enoic acid | C20:1n15 | Omega-9 | C20H38O2 | CH3(CH2)7CH=CH(CH2)9COOH | ![]() |
| Erucic acid | (13Z)-docos-13-enoic acid | C22:1n9 | Omega-9 | C22H42O2 | CH3(CH2)7CH=CH(CH2)11COOH | ![]() |
| Nervonic acid | (15Z)-tetracos-15-enoic acid | C24:1n9 | omega-9 | C24H46O2 | CH3(CH2)7CH=CH(CH2)13COOH | ![]() |
| Trivial Name | IUPAC Name: Systematic: | Abbreviation | Omega | Molecular Formula | Linear Chemical Formula | Structural Chemical Formula |
|---|---|---|---|---|---|---|
| Linoleic acid | (9Z,12Z)-octadeca-9,12-dienoic acid | C18:2n6c | Omega 6 | C18H32O2 | CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH | ![]() |
| Linoelaidic acid | (9E,12E)-octadeca-9,12-dienoic acid | C18:2n6t | Omega-6 | C18H32O2 | CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH | ![]() |
| (all-cis)-11,14-eicosadienoic acid | (11Z,14Z)-eicosa-11,14-dienoic acid | C20:2n6 | Omega-6 | C20H36O2 | CH3(CH2)4(CH=CHCH2)2(CH2)8COOH | ![]() |
| (all-cis)-13,16-docosadienoic acid | (13Z,16Z)-docosa-13,16-dienoic acid | C22:2n6 | Omega-6 | C22H40O2 | CH3(CH2)4(CH=CHCH2)2(CH2)8COOH | ![]() |
| GLA γ-linolenic acid | (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid | C18:3n6 (gamma) | Omega-6 | C18H30O2 | CH3(CH2)4CH=CHCH2CH=CHCH2CH=CH(CH2)4COOH (all cis) | ![]() |
| α-linolenic acid | (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid | C18:3n3 (alpha) | Omega-3 | C18H30O | CH3(CH2CH=CH)3(CH2)7COOH | ![]() |
| DGLA. Dihomo-γ-linolenic acid | (8Z,11Z,14Z)-eicosa-8,11,14-trienoic acid | 20:3n6 | Omega-6 | C20H34O2 | CH3(CH2)3(CH2CH=CH)3(CH2)6COOH | ![]() |
| (all-cis)-11,14,17-eicosatrienoic acid | (11Z,14Z,17Z)-eicosa-11,14,17-trienoic acid | C20:3n3 | Omega-3 | C21H36O2 | CH3(CH2)2CH=CHCH2CH=CHCH2CH=CH(CH2)9COOH | ![]() |
| Arachidonic acid | (5Z,8Z,11Z,14Z)-eicosa-5,8,11,14-tetraenoic acid | C20:4n6 | Omega-6 | C20H32O2 | CH3(CH2)4(CH=CHCH2)4CH2CH2COOH | ![]() |
| EPA. Timnodonic acid | (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoic acid | C20:5n3 | Omega-3 | C20H30O2 | CH3(CH2CH=CH)5(CH2)3COOH | ![]() |
| DHA. Cervonic acid | (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid | C22:6n3 | Omega-3 | C22H32O2 | CH3(CH2CHCH)6CH2CH2COOH | ![]() |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Chwil, M.; Neugebauerová, J.; Matraszek-Gawron, R.; Paszko, T. Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species. Molecules 2026, 31, 1425. https://doi.org/10.3390/molecules31091425
Chwil M, Neugebauerová J, Matraszek-Gawron R, Paszko T. Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species. Molecules. 2026; 31(9):1425. https://doi.org/10.3390/molecules31091425
Chicago/Turabian StyleChwil, Mirosława, Jarmila Neugebauerová, Renata Matraszek-Gawron, and Tadeusz Paszko. 2026. "Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species" Molecules 31, no. 9: 1425. https://doi.org/10.3390/molecules31091425
APA StyleChwil, M., Neugebauerová, J., Matraszek-Gawron, R., & Paszko, T. (2026). Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species. Molecules, 31(9), 1425. https://doi.org/10.3390/molecules31091425




















































